Prescription ID | TCMF5993 |
Pinyin Name | Chang Chun Bao Kou Fu Ye |
Chinese Name | 长春宝口服液 |
English Name | Chang Chun Bao Oral Liquid |
Function Description | 虚劳, 眩晕, 视瞻昏渺, 耳鸣, 健忘, 不寐 |
Indications | Tinnitus disorder, Vertigo disorder, Forgetfulness disorder, Consumptive disorder, Insomnia disorder, Insomnia, Tinnitus, Dizziness |
Disease ICD-11 Category |
SC75 [Tinnitus disorder (TM1), 耳鸣 (TM1)
]; SD22 [Vertigo disorder (TM1), 眩晕 (TM1) ]; SD23 [Forgetfulness disorder (TM1), 健忘 (TM1) ]; SD72 [Consumptive disorder (TM1), 虚劳 (TM1) ]; SD84 [Insomnia disorder (TM1), 不寐 (TM1) ]; 7A0Z [Insomnia disorders, unspecified, 失眠障碍,未特指的 ]; MC41 [Tinnitus, 耳鸣 ]; MB48 [Dizziness and giddiness, 头晕和眩晕 ]; |
Human Tissues Associated with Indication | Brain, Heart |
Reference | CFDA |
Reference Book/link | http://samr.cfda.gov.cn/WS01/CL0001/ |
Component ID | Latin Name | Chinese Name | Component Quantity | Barcode |
---|---|---|---|---|
TCMH1721 | Panax ginseng | 人参 | TCMH1721 | GBVE1679-11 |
TCMH1186 | Lycium chinense | 枸杞子 | TCMH1186 | ITSAO4545-14 |
TCMH1845 | Dioscorea batatas | 山药 | TCMH1845 | |
TCMH2202 | Schisandra chinensis | 五味子 | TCMH2202 | ITSAM2867-14 |
TCMH2084 | Asparagus cochinchinensis | 天冬 | TCMH2084 | ITSAJ4142-14 |
TCMH1423 | Ophiopogon japonicus | 麦冬 | TCMH1423 | ITSAJ4140-14 |
TCMH451 | Rehmannia glutinosa | 地黄 | TCMH451 | ITSAH4578-14 |
TCMH1966 | Rehmannia glutinosa | 熟地黄 | TCMH1966 | ITSAH4578-14 |
TCMH819 | Polygonum multiflorum | 何首乌 | TCMH819 | ITSAL419-14 |
TCMH606 | Wolfiporia cocos | 茯苓 | TCMH606 | GBPOL314-13 |
TCMH1588 | Achyranthes bidentata | 牛膝 | TCMH1588 | ITSAJ4612-14 |
TCMH421 | Angelica sinensis | 当归 | TCMH421 | ITSAF173-14 |
TCMH193 | Psoralea corylifolia | 补骨脂 | TCMH193 | |
TCMH524 | Eucommia ulmoides | 杜仲 | TCMH524 | ITSAM1588-14 |
TCMH31 | Morinda officinalis | 巴戟天 | TCMH31 | ITSAJ4459-14 |
TCMH2624 | Anemarrhena asphodeloides | 知母 | TCMH2624 | GBVA3255-11, GBVU1201-13 |
TCMH949 | Phellodendron amurense | 黄柏 | TCMH949 | ITSAM1586-14 |
TCMH2256 | Curculigo orchioides | 仙茅 | TCMH2256 | GENG778-14 |
TCMH2507 | Epimedium brevicornum | 淫羊藿 | TCMH2507 | AY362429 |
TCMH2581 | Alisma orientale | 泽泻 | TCMH2581 | KC573871 |
TCMH407 | Salvia miltiorrhiza | 丹参 | TCMH407 | ITSAH2408-14 |
TCMH981 | Astragalus membranaceus | 黄芪 | TCMH981 | ITSAK2981-14 |
TCMH1791 | Loranthus parasiticus | 桑寄生 | TCMH1791 | |
TCMH1597 | Ligustrum lucidum | 女贞子 | TCMH1597 | ITSAM2109-14 |
TCMH1503 | Eclipta prostrata | 墨旱莲 | TCMH1503 | ITSAP4516-14 |
Target ID | Gene Symbol | Target Name | Target Class | Uniprot ID |
---|---|---|---|---|
TCMT100 | TTR | Transthyretin | Unclassified | P02766 |
TCMT101 | PTPN1 | Protein-tyrosine phosphatase 1B | Hydrolase | P18031 |
TCMT102 | ACP1 | Low molecular weight phosphotyrosine protein phosphatase | Hydrolase | P24666 |
TCMT103 | PTPRF | Receptor-type tyrosine-protein phosphatase F (LAR) | Hydrolase | P10586 |
TCMT107 | GRIK2 | Glutamate receptor ionotropic kainate 2 | Ion channel | Q13002 |
TCMT109 | GRIA2 | Glutamate receptor ionotropic, AMPA 2 | Ion channel | P42262 |
TCMT110 | GRIA4 | Glutamate receptor ionotropic, AMPA 4 | Ion channel | P48058 |
TCMT111 | GRIK5 | Glutamate receptor ionotropic kainate 5 | Ion channel | Q16478 |
TCMT112 | ADORA3 | Adenosine A3 receptor | GPCR | P0DMS8 |
TCMT126 | TERT | Telomerase reverse transcriptase | Transferase | O14746 |
TCMT127 | PARP1 | Poly [ADP-ribose] polymerase-1 | Transferase | P09874 |
TCMT130 | ALOX5 | Arachidonate 5-lipoxygenase | Oxidoreductase | P09917 |
TCMT131 | ACHE | Acetylcholinesterase | Hydrolase | P22303 |
TCMT133 | CA1 | Carbonic anhydrase I | Lyase | P00915 |
TCMT134 | CA2 | Carbonic anhydrase II | Lyase | P00918 |
TCMT135 | CA14 | Carbonic anhydrase XIV | Lyase | Q9ULX7 |
TCMT136 | CA12 | Carbonic anhydrase XII | Lyase | O43570 |
TCMT137 | CA9 | Carbonic anhydrase IX | Lyase | Q16790 |
TCMT138 | CA7 | Carbonic anhydrase VII | Lyase | P43166 |
TCMT139 | CA6 | Carbonic anhydrase VI | Lyase | P23280 |
TCMT140 | CA5B | Carbonic anhydrase VB | Lyase | Q9Y2D0 |
TCMT141 | CA5A | Carbonic anhydrase VA | Lyase | P35218 |
TCMT142 | CA4 | Carbonic anhydrase IV | Lyase | P22748 |
TCMT150 | RORC | Nuclear receptor ROR-gamma | Nuclear receptor | P51449 |
TCMT156 | CYP19A1 | Cytochrome P450 19A1 | Oxidoreductase | P11511 |
TCMT159 | TYR | Tyrosinase | Oxidoreductase | P14679 |
TCMT161 | HCAR2 | Hydroxycarboxylic acid receptor 2 | GPCR | Q8TDS4 |
TCMT162 | UGT1A1 | UDP-glucuronosyltransferase 1-1 | Transferase | P22309 |
TCMT164 | PTGS1 | Cyclooxygenase-1 | Oxidoreductase | P23219 |
TCMT171 | PTPN6 | Protein-tyrosine phosphatase 1C | Hydrolase | P29350 |
TCMT174 | HSD11B1 | 11-beta-hydroxysteroid dehydrogenase 1 | Oxidoreductase | P28845 |
TCMT186 | MAOB | Monoamine oxidase B | Oxidoreductase | P27338 |
TCMT190 | PTPN2 | T-cell protein-tyrosine phosphatase | Hydrolase | P17706 |
TCMT197 | PDE4D | Phosphodiesterase 4D | Hydrolase | Q08499 |
TCMT206 | CYP2A6 | Cytochrome P450 2A6 | Oxidoreductase | P11509 |
TCMT210 | CES2 | Carboxylesterase 2 | Hydrolase | O00748 |
TCMT211 | CES1 | Acyl coenzyme A:cholesterol acyltransferase | Transferase | P23141 |
TCMT212 | SRC | Tyrosine-protein kinase SRC | Kinase | P12931 |
TCMT215 | CYP1A1 | Cytochrome P450 1A1 | Oxidoreductase | P04798 |
TCMT217 | CYP2C8 | Cytochrome P450 2C8 | Oxidoreductase | P10632 |
TCMT219 | CYP1A2 | Cytochrome P450 1A2 | Oxidoreductase | P05177 |
TCMT223 | AKR1B1 | Aldose reductase | Oxidoreductase | P15121 |
TCMT23 | ALPL | Alkaline phosphatase, tissue-nonspecific isozyme | Hydrolase | P05186 |
TCMT233 | PTPN11 | Protein-tyrosine phosphatase 2C | Hydrolase | Q06124 |
TCMT236 | ESR2 | Estrogen receptor beta | Nuclear receptor | Q92731 |
TCMT239 | PIM1 | Serine/threonine-protein kinase PIM1 | Kinase | P11309 |
TCMT240 | AMY1A | Salivary alpha-amylase | Unclassified | P04745 |
TCMT247 | ADRA2A | Alpha-2a adrenergic receptor | GPCR | P08913 |
TCMT254 | CBR1 | Carbonyl reductase [NADPH] 1 | Oxidoreductase | P16152 |
TCMT257 | CYP1B1 | Cytochrome P450 1B1 | Oxidoreductase | Q16678 |
TCMT260 | FLT3 | Tyrosine-protein kinase receptor FLT3 | Kinase | P36888 |
TCMT261 | DAPK1 | Death-associated protein kinase 1 | Kinase | P53355 |
TCMT268 | CYP2A13 | Cytochrome P450 2A13 | Oxidoreductase | Q16696 |
TCMT27 | DRD1 | Dopamine D1 receptor | GPCR | P21728 |
TCMT280 | AKR1B10 | Aldo-keto reductase family 1 member B10 | Oxidoreductase | O60218 |
TCMT281 | DPP4 | Dipeptidyl peptidase IV | Unclassified | P27487 |
TCMT283 | PTPRS | Receptor-type tyrosine-protein phosphatase S | Hydrolase | Q13332 |
TCMT290 | CHRM5 | Muscarinic acetylcholine receptor M5 | GPCR | P08912 |
TCMT291 | CHRM3 | Muscarinic acetylcholine receptor M3 | GPCR | P20309 |
TCMT292 | CHRM1 | Muscarinic acetylcholine receptor M1 | GPCR | P11229 |
TCMT293 | CHRM2 | Muscarinic acetylcholine receptor M2 | GPCR | P08172 |
TCMT295 | MMP1 | Matrix metalloproteinase-1 | Hydrolase | P03956 |
TCMT296 | ADORA1 | Adenosine A1 receptor | GPCR | P30542 |
TCMT297 | FABP4 | Fatty acid binding protein adipocyte | Unclassified | P15090 |
TCMT298 | FABP3 | Fatty acid binding protein muscle | Hydrolase | P05413 |
TCMT3 | ALOX15 | Arachidonate 15-lipoxygenase | Oxidoreductase | P16050 |
TCMT30 | PTGS2 | Cyclooxygenase-2 | Oxidoreductase | P35354 |
TCMT306 | MMP2 | Matrix metalloproteinase-2 | Hydrolase | P08253 |
TCMT307 | KCNH2 | HERG | Ion channel | Q12809 |
TCMT31 | CYP2C19 | Cytochrome P450 2C19 | Oxidoreductase | P33261 |
TCMT321 | MMP9 | Matrix metalloproteinase 9 | Hydrolase | P14780 |
TCMT322 | MMP13 | Matrix metalloproteinase 13 | Hydrolase | P45452 |
TCMT327 | TRPV1 | Vanilloid receptor | Ion channel | Q8NER1 |
TCMT329 | NQO2 | Quinone reductase 2 | Oxidoreductase | P16083 |
TCMT33 | CYP3A4 | Cytochrome P450 3A4 | Oxidoreductase | P08684 |
TCMT34 | CYP2D6 | Cytochrome P450 2D6 | Oxidoreductase | P10635 |
TCMT344 | AOX1 | Aldehyde oxidase | Oxidoreductase | Q06278 |
TCMT359 | FYN | Tyrosine-protein kinase FYN | Kinase | P06241 |
TCMT369 | IGF1R | Insulin-like growth factor I receptor | Kinase | P08069 |
TCMT370 | KDR | Vascular endothelial growth factor receptor 2 | Kinase | P35968 |
TCMT374 | AURKB | Serine/threonine-protein kinase Aurora-B | Kinase | Q96GD4 |
TCMT38 | DRD2 | Dopamine D2 receptor | GPCR | P14416 |
TCMT384 | GRK6 | G protein-coupled receptor kinase 6 | Kinase | P43250 |
TCMT388 | AXL | Tyrosine-protein kinase receptor UFO | Kinase | P30530 |
TCMT39 | PDE5A | Phosphodiesterase 5A | Hydrolase | O76074 |
TCMT401 | MET | Hepatocyte growth factor receptor | Kinase | P08581 |
TCMT422 | CAMK2B | CaM kinase II beta | Kinase | Q13554 |
TCMT445 | NEK2 | Serine/threonine-protein kinase NEK2 | Kinase | P51955 |
TCMT46 | F3 | Coagulation factor III | Unclassified | P13726 |
TCMT462 | NEK6 | Serine/threonine-protein kinase NEK6 | Kinase | Q9HC98 |
TCMT479 | AKT1 | Serine/threonine-protein kinase AKT | Kinase | P31749 |
TCMT484 | PLK1 | Serine/threonine-protein kinase PLK1 | Kinase | P53350 |
TCMT508 | SYK | Tyrosine-protein kinase SYK | Kinase | P43405 |
TCMT563 | CDC25B | Dual specificity phosphatase Cdc25B | Hydrolase | P30305 |
TCMT591 | ESRRA | Estrogen-related receptor alpha | Nuclear receptor | P11474 |
TCMT592 | XDH | Xanthine dehydrogenase | Oxidoreductase | P47989 |
TCMT597 | SLC28A3 | Solute carrier family 28 member 3 | Transporter | Q9HAS3 |
TCMT599 | UBE2N | Ubiquitin-conjugating enzyme E2 N | Transferase | P61088 |
TCMT61 | MCL1 | Induced myeloid leukemia cell differentiation protein Mcl-1 | Unclassified | Q07820 |
TCMT613 | NR3C1 | Glucocorticoid receptor | Nuclear receptor | P04150 |
TCMT614 | EGLN1 | Egl nine homolog 1 | Oxidoreductase | Q9GZT9 |
TCMT619 | HSP90AA1 | Heat shock protein HSP 90-alpha | Unclassified | P07900 |
TCMT624 | HSP90AB1 | Heat shock protein HSP 90-beta | Unclassified | P08238 |
TCMT63 | PPARA | Peroxisome proliferator-activated receptor alpha | Nuclear receptor | Q07869 |
TCMT633 | SLC6A4 | Serotonin transporter | Transporter | P31645 |
TCMT634 | SLC6A2 | Norepinephrine transporter | Transporter | P23975 |
TCMT637 | SIRT3 | NAD-dependent deacetylase sirtuin 3 | Hydrolase | Q9NTG7 |
TCMT638 | SIRT2 | NAD-dependent deacetylase sirtuin 2 | Hydrolase | Q8IXJ6 |
TCMT65 | HSD17B1 | Estradiol 17-beta-dehydrogenase 1 | Oxidoreductase | P14061 |
TCMT653 | GRM1 | Metabotropic glutamate receptor 1 | GPCR | Q13255 |
TCMT654 | GRM5 | Metabotropic glutamate receptor 5 | GPCR | P41594 |
TCMT655 | GRM2 | Metabotropic glutamate receptor 2 | GPCR | Q14416 |
TCMT656 | GRM3 | Metabotropic glutamate receptor 3 | GPCR | Q14832 |
TCMT657 | GRM4 | Metabotropic glutamate receptor 4 | GPCR | Q14833 |
TCMT66 | HSD17B2 | Estradiol 17-beta-dehydrogenase 2 | Oxidoreductase | P37059 |
TCMT660 | GRM8 | Metabotropic glutamate receptor 8 | GPCR | O00222 |
TCMT664 | SLC1A1 | Excitatory amino acid transporter 3 | Transporter | P43005 |
TCMT67 | PPARG | Peroxisome proliferator-activated receptor gamma | Nuclear receptor | P37231 |
TCMT690 | HDAC3 | Histone deacetylase 3 | Hydrolase | O15379 |
TCMT698 | PDE4B | Phosphodiesterase 4B | Hydrolase | Q07343 |
TCMT709 | SLC28A2 | Sodium/nucleoside cotransporter 2 | Transporter | O43868 |
TCMT710 | SLC28A1 | Sodium/nucleoside cotransporter 1 | Transporter | O00337 |
TCMT718 | TXN2 | Thioredoxin, mitochondrial | Unclassified | Q99757 |
TCMT719 | TXN | Thioredoxin | Unclassified | P10599 |
TCMT729 | PIK3CA | PI3-kinase p110-alpha subunit | Transferase | P42336 |
TCMT730 | PIK3CB | PI3-kinase p110-beta subunit | Transferase | P42338 |
TCMT734 | MMP12 | Matrix metalloproteinase 12 | Hydrolase | P39900 |
TCMT752 | CSNK2A1 | Casein kinase II alpha | Kinase | P68400 |
TCMT771 | ATR | Serine-protein kinase ATR | Kinase | Q13535 |
TCMT784 | AVPR2 | Vasopressin V2 receptor | GPCR | P30518 |
TCMT785 | CXCR1 | Interleukin-8 receptor A | GPCR | P25024 |
TCMT786 | CCR4 | C-C chemokine receptor type 4 | GPCR | P51679 |
TCMT791 | PKN1 | Protein kinase N1 | Kinase | Q16512 |
TCMT793 | PYGL | Liver glycogen phosphorylase | Transferase | P06737 |
TCMT8 | KDM4E | Lysine-specific demethylase 4D-like | Oxidoreductase | B2RXH2 |
TCMT808 | FABP5 | Fatty acid binding protein epidermal | Unclassified | Q01469 |
TCMT809 | FABP2 | Fatty acid binding protein intestinal | Unclassified | P12104 |
TCMT81 | ALOX12 | Arachidonate 12-lipoxygenase | Oxidoreductase | P18054 |
TCMT810 | TLR2 | Toll-like receptor 2 | Unclassified | O60603 |
TCMT82 | ESR1 | Estrogen receptor alpha | Nuclear receptor | P03372 |
TCMT822 | FUT7 | Alpha-(1,3)-fucosyltransferase 7 | Transferase | Q11130 |
TCMT83 | CD38 | Lymphocyte differentiation antigen CD38 | Unclassified | P28907 |
TCMT848 | ERN1 | Serine/threonine-protein kinase/endoribonuclease IRE1 | Kinase | O75460 |
TCMT87 | CYP2C9 | Cytochrome P450 2C9 | Oxidoreductase | P11712 |
TCMT910 | ESRRB | Estrogen-related receptor beta | Nuclear receptor | O95718 |
Target ID | Target Name |
---|---|
TCMT1168 | Trichomonas vaginalis |
TCMT1170 | Enterobacter cloacae |
TCMT1172 | Staphylococcus aureus subsp. aureus RN4220 |
TCMT1175 | Human immunodeficiency virus |
TCMT1176 | Streptococcus pneumoniae |
TCMT1178 | Actinomyces viscosus |
TCMT1179 | Escherichia coli ATCC 8739 |
TCMT1180 | Human herpesvirus 2 |
TCMT1181 | Mycobacterium tuberculosis H37Ra |
TCMT1182 | Streptococcus sanguinis |
TCMT1189 | Pseudomonas fluorescens |
TCMT1190 | Plasmodium falciparum (isolate FcB1 / Columbia) |
TCMT1208 | Escherichia coli K12 |
TCMT1209 | Staphylococcus haemolyticus |
TCMT1211 | Fusobacterium nucleatum |
TCMT1212 | Verticillium dahliae |
TCMT1213 | Neisseria gonorrhoeae |
TCMT1215 | Pseudomonas aeruginosa PAO1 |
TCMT1218 | Staphylococcus aureus |
TCMT1221 | Human herpesvirus 4 |
TCMT1222 | Plasmodium falciparum D6 |
TCMT1223 | Staphylococcus epidermidis |
TCMT1226 | Klebsiella pneumoniae |
TCMT1227 | Streptococcus |
TCMT1229 | Enterococcus faecalis |
TCMT1230 | Human herpesvirus 5 |
TCMT1231 | Human herpesvirus 1 strain KOS |
TCMT1232 | Pseudomonas aeruginosa |
TCMT1236 | Mycobacterium bovis |
TCMT1243 | Aspergillus flavus |
TCMT1245 | Phytophthora cactorum |
TCMT1246 | Escherichia coli |
TCMT1247 | Human herpesvirus 1 |
TCMT1248 | Hepatitis C virus |
TCMT1249 | Dengue virus 2 |
TCMT1250 | Vesicular stomatitis virus |
TCMT1251 | Candida albicans |
TCMT1253 | Penicillium chrysogenum |
TCMT1255 | Human immunodeficiency virus 1 |
TCMT1284 | Penicillium expansum |
TCMT1286 | Bacillus cereus |
TCMT1289 | Shigella dysenteriae |
TCMT1292 | Japanese encephalitis virus |
TCMT1294 | Human parainfluenza virus 3 |
TCMT1305 | Salmonella enteritidis |
TCMT1318 | Human T-lymphotropic virus 1 |
TCMT1336 | Yellow fever virus |
TCMT1337 | Dengue virus type 4 |
TCMT1338 | Rift Valley fever virus |
TCMT1346 | Helicobacter pylori |
TCMT1349 | Helicobacter pylori SS1 |
TCMT1353 | Plasmodium yoelii |
TCMT1354 | Streptococcus mutans UA159 |
TCMT1361 | Neisseria meningitidis |
TCMT1382 | Plasmodium falciparum (isolate K1 / Thailand) |
TCMT1385 | Candida shehatae |
TCMT1390 | Human herpesvirus 2 strain G |
TCMT1393 | Vibrio sp. |
TCMT1405 | Penicillium citrinum |
TCMT1408 | Colletotrichum gloeosporioides |
TCMT1412 | Salmonella typhimurium |
TCMT1438 | Plasmodium falciparum |
TCMT1439 | Mycobacterium smegmatis |
TCMT1442 | Leishmania donovani |
TCMT1443 | Leishmania amazonensis |
TCMT1444 | Fusarium oxysporum |
TCMT1447 | Respiratory syncytial virus |
TCMT1448 | Enterobacter aerogenes |
TCMT1449 | Influenza A virus |
TCMT1450 | Plasmodium falciparum 3D7 |
TCMT1454 | Bacillus subtilis |
TCMT1455 | Mycobacterium tuberculosis H37Rv |
TCMT1458 | Filobasidiella neoformans |
TCMT1460 | Mycobacterium intracellulare |
TCMT1462 | Streptococcus mutans |
TCMT1463 | Mycobacterium tuberculosis |
TCMT1464 | Hepatitis B virus |
TCMT1465 | Entamoeba histolytica |
GO Term | GO Name | Enriched Genes | Log10 Adjusted P-value |
---|---|---|---|
[BP] GO:0006629 | lipid metabolic process | ACHE, ADORA1, AKR1B1, AKR1B10, ALOX12, ALOX15, ALOX5, CBR1, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, CYP3A4, DRD2, ESR1, FABP3, FABP4, FUT7, HSD11B1, HSD17B1, HSD17B2, MET, PIK3CA, PIK3CB, PPARA, PPARG, PTGS1, PTGS2, TRPV1 | 14.7519 |
[BP] GO:0019369 | arachidonic acid metabolic process | ALOX12, ALOX15, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, PTGS1, PTGS2 | 12.8527 |
[BP] GO:0033559 | unsaturated fatty acid metabolic process | ALOX12, ALOX15, ALOX5, CBR1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, PTGS1, PTGS2 | 12.8184 |
[BP] GO:0065008 | regulation of biological quality | ACHE, ADORA1, ADRA2A, AKR1B1, ALOX12, ALOX15, AURKB, AXL, CA12, CA2, CA7, CHRM1, CHRM3, CYP19A1, CYP1A1, CYP1B1, CYP3A4, DRD1, DRD2, ESR1, F3, FABP3, FABP4, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM5, HCAR2, HSD11B1, HSD17B1, HSD17B2, HSP90AA1, HSP90AB1, KCNH2, KDR, MAOB, MCL1, MET, PIK3CA, PIK3CB, PPARA, PPARG, PTGS1, PTGS2, SLC1A1, SLC6A2, SLC6A4, SRC, TERT, TRPV1, XDH | 12.8184 |
[BP] GO:0006690 | icosanoid metabolic process | ALOX12, ALOX15, ALOX5, CBR1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, PTGS1, PTGS2 | 12.5016 |
[BP] GO:0044281 | small molecule metabolic process | AKR1B1, AKR1B10, ALOX12, ALOX15, ALOX5, AOX1, CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CBR1, CES1, CES2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, CYP3A4, FABP3, FUT7, PDE5A, PIK3CA, PIM1, PPARA, PPARG, PTGS1, PTGS2, TYR, XDH | 12.0325 |
[BP] GO:0006631 | fatty acid metabolic process | ALOX12, ALOX15, ALOX5, CBR1, CES1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, FABP3, PPARA, PPARG, PTGS1, PTGS2 | 10.9219 |
[BP] GO:0015701 | bicarbonate transport | CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9 | 10.7463 |
[BP] GO:0042221 | response to chemical | ADRA2A, AKR1B1, ALOX15, ALPL, AXL, CA2, CA9, CES1, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, ESR1, ESRRA, FABP3, FABP4, FLT3, GRIK5, GRM5, HSD17B2, HSP90AA1, HSP90AB1, IGF1R, KCNH2, KDR, MAOB, MCL1, MMP2, MMP9, NR3C1, PIK3CA, PPARA, PPARG, PTGS2, RORC, SLC6A2, SLC6A4, SRC, TERT, TRPV1, TYR | 10.7463 |
[BP] GO:0044255 | cellular lipid metabolic process | ACHE, AKR1B10, ALOX12, ALOX15, ALOX5, CBR1, CES1, CES2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, CYP3A4, DRD2, FABP3, FABP4, FUT7, MET, PIK3CA, PIK3CB, PPARA, PPARG, PTGS1, PTGS2 | 10.7463 |
[BP] GO:0006805 | xenobiotic metabolic process | CES1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2C19, CYP2D6, CYP3A4, HSP90AB1, NQO2, PTGS1, RORC | 10.7463 |
[BP] GO:1901568 | fatty acid derivative metabolic process | ALOX12, ALOX15, ALOX5, CBR1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, PTGS1, PTGS2 | 10.381 |
[BP] GO:1901700 | response to oxygen-containing compound | AKR1B1, ALPL, AXL, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, ESR1, ESRRA, FABP3, GRIK5, GRM5, HSD17B2, HSP90AB1, IGF1R, MAOB, MMP2, MMP9, NR3C1, PIK3CA, PPARA, PPARG, PTGS2, RORC, SLC6A4, SRC, TRPV1, TYR | 10.2557 |
[BP] GO:0010033 | response to organic substance | ADRA2A, AKR1B1, ALOX15, ALPL, AXL, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, ESR1, ESRRA, FABP3, FABP4, FLT3, GRIK5, GRM5, HSD17B2, HSP90AA1, HSP90AB1, IGF1R, KDR, MAOB, MCL1, MMP2, NR3C1, PIK3CA, PPARA, PPARG, PTGS2, RORC, SLC6A4, SRC, TRPV1, TYR | 10.2552 |
[BP] GO:0001676 | long-chain fatty acid metabolic process | ALOX12, ALOX15, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, PTGS1, PTGS2 | 10.0906 |
[BP] GO:0006730 | one-carbon metabolic process | CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9 | 9.99753 |
[BP] GO:0007193 | None | ADORA1, ADRA2A, CHRM1, CHRM2, CHRM3, CHRM5, DRD2, GRM1, GRM3, GRM5, GRM8 | 9.99583 |
[BP] GO:0055114 | oxidation-reduction process | AKR1B1, AKR1B10, ALOX12, ALOX15, ALOX5, AOX1, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, CYP3A4, HSD11B1, HSD17B1, HSD17B2, MAOB, NQO2, PPARG, PTGS1, PTGS2, TYR, XDH | 9.91689 |
[BP] GO:0008202 | steroid metabolic process | AKR1B1, AKR1B10, CES1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2C19, CYP2D6, CYP3A4, ESR1, HSD11B1, HSD17B1, HSD17B2 | 9.01973 |
[BP] GO:0019748 | secondary metabolic process | AKR1B1, AKR1B10, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, TYR | 8.67757 |
[BP] GO:0014070 | response to organic cyclic compound | ALPL, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, ESR1, ESRRA, FLT3, HSP90AB1, MAOB, NR3C1, PPARG, PTGS2, RORC, SLC6A4, SRC, TRPV1, TYR | 8.42739 |
[BP] GO:0007188 | None | ADORA1, ADRA2A, CHRM1, CHRM2, CHRM3, CHRM5, DRD1, DRD2, GRM1, GRM3, GRM5, GRM8 | 8.05244 |
[BP] GO:0032787 | None | ALOX12, ALOX15, ALOX5, CBR1, CES1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, FABP3, PPARA, PPARG, PTGS1, PTGS2 | 7.98181 |
[BP] GO:0048522 | positive regulation of cellular process | ACHE, ADORA1, ADRA2A, AKR1B1, ALOX12, ALOX15, AURKB, AXL, CA2, CA7, CDC25B, CHRM1, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FLT3, GRIK5, GRM1, GRM5, HCAR2, HSP90AA1, HSP90AB1, IGF1R, KCNH2, KDR, MAOB, MCL1, MET, MMP1, MMP12, MMP2, MMP9, NR3C1, PDE5A, PIK3CA, PIK3CB, PIM1, PPARA, PPARG, PTGS2, PTPN1, RORC, SLC6A4, SRC, TERT, TRPV1, XDH | 7.89513 |
[BP] GO:0008152 | metabolic process | ACHE, ADORA1, AKR1B1, AKR1B10, ALOX12, ALOX15, ALOX5, ALPL, AOX1, AURKB, AXL, CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CBR1, CDC25B, CES1, CES2, CHRM1, CHRM3, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, CYP3A4, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, FUT7, HSD11B1, HSD17B1, HSD17B2, HSP90AA1, HSP90AB1, IGF1R, KCNH2, KDR, MAOB, MET, MMP1, MMP12, MMP2, MMP9, NQO2, NR3C1, PDE5A, PIK3CA, PIK3CB, PIM1, PPARA, PPARG, PTGS1, PTGS2, PTPN1, PTPRS, RORC, SLC6A4, SRC, TERT, TRPV1, TYR, XDH | 7.73726 |
[BP] GO:0048518 | positive regulation of biological process | ACHE, ADORA1, ADRA2A, AKR1B1, ALOX12, ALOX15, AURKB, AXL, CA2, CA7, CDC25B, CHRM1, CHRM3, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, GRIK5, GRM1, GRM5, HCAR2, HSP90AA1, HSP90AB1, IGF1R, KCNH2, KDR, MAOB, MCL1, MET, MMP1, MMP12, MMP2, MMP9, NR3C1, PDE5A, PIK3CA, PIK3CB, PIM1, PPARA, PPARG, PTGS2, PTPN1, RORC, SLC1A1, SLC6A4, SRC, TERT, TRPV1, XDH | 7.66836 |
[BP] GO:0042592 | homeostatic process | ADORA1, ADRA2A, AKR1B1, ALOX12, AXL, CA12, CA2, CA7, DRD1, DRD2, ESR1, FABP3, FABP4, FLT3, GRIK5, GRM1, GRM5, HSP90AA1, HSP90AB1, KCNH2, MCL1, MET, PIK3CA, PIK3CB, PPARG, SRC, TERT, TRPV1 | 7.65306 |
[BP] GO:0070887 | cellular response to chemical stimulus | ADRA2A, AKR1B1, ALOX15, ALPL, AXL, CYP1A1, CYP1A2, CYP1B1, DRD1, ESR1, FABP4, FLT3, GRIK5, GRM5, HSP90AB1, IGF1R, KCNH2, KDR, MMP2, MMP9, NR3C1, PIK3CA, PPARG, PTGS2, RORC, SLC6A4, SRC, TERT, TRPV1 | 7.50174 |
[BP] GO:0007187 | None | ADORA1, ADRA2A, CHRM1, CHRM2, CHRM3, CHRM5, DRD1, DRD2, GRM1, GRM3, GRM5, GRM8 | 7.34637 |
[BP] GO:0010647 | positive regulation of cell communication | ADORA1, ADRA2A, AKR1B1, ALOX15, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, F3, FLT3, GRM1, HCAR2, HSP90AB1, KDR, MCL1, MET, MMP12, MMP9, PDE5A, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, TERT, XDH | 7.15752 |
[BP] GO:0023056 | positive regulation of signaling | ADORA1, ADRA2A, AKR1B1, ALOX15, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, F3, FLT3, GRM1, HCAR2, HSP90AB1, KDR, MCL1, MET, MMP12, MMP9, PDE5A, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, TERT, XDH | 7.12046 |
[BP] GO:0015711 | organic anion transport | CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, DRD2, FABP3, PPARA, PPARG, SLC1A1, TRPV1 | 7.05847 |
[BP] GO:0032501 | multicellular organismal process | ADORA1, ADRA2A, AKR1B1, AKR1B10, ALOX12, ALOX15, ALOX5, ALPL, AXL, CHRM1, CHRM3, CHRM5, CYP19A1, CYP1A2, CYP1B1, DRD1, DRD2, ESR1, ESRRB, F3, FABP4, GRM1, GRM5, GRM8, HSD17B2, IGF1R, KCNH2, MCL1, MET, MMP1, MMP12, MMP2, MMP9, PDE5A, PIK3CA, PIM1, PPARA, PTGS2, RORC, SLC6A2, SLC6A4, SRC, TRPV1, TYR | 7.01951 |
[BP] GO:0033993 | response to lipid | ALPL, AXL, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, ESR1, ESRRA, FABP3, FLT3, HSD17B2, MAOB, NR3C1, PPARG, PTGS2, RORC, SLC6A4, SRC, TYR | 6.94042 |
[BP] GO:0009719 | response to endogenous stimulus | ADRA2A, AKR1B1, ALPL, CA2, CA9, CSNK2A1, CYP1A2, DRD1, ESR1, ESRRA, FABP3, FLT3, GRM5, IGF1R, MAOB, MMP2, NR3C1, PPARA, PPARG, PTGS2, SLC6A4, SRC, TRPV1 | 6.90268 |
[BP] GO:0001505 | regulation of neurotransmitter levels | ACHE, CYP1B1, DRD1, DRD2, GRIK5, HSP90AA1, HSP90AB1, MAOB, PTGS2, SLC1A1, SLC6A2, SLC6A4, TRPV1 | 6.84929 |
[BP] GO:0007200 | None | ADRA2A, CHRM1, CHRM2, CHRM3, CHRM5, DRD1, DRD2, ESR1, GRM5 | 6.80249 |
[BP] GO:0051966 | regulation of synaptic transmission, glutamatergic | ADORA1, DRD1, DRD2, GRM1, GRM3, GRM5, GRM8, PTGS2 | 6.7908 |
[BP] GO:0009725 | response to hormone | ADRA2A, AKR1B1, ALPL, CA2, CA9, CSNK2A1, CYP1A2, ESR1, ESRRA, FABP3, FLT3, MAOB, NR3C1, PPARA, PPARG, PTGS2, SLC6A4, SRC, TRPV1 | 6.78669 |
[BP] GO:0019373 | epoxygenase P450 pathway | CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19 | 6.68318 |
[BP] GO:0043067 | regulation of programmed cell death | ADORA1, AKR1B1, ALOX12, AURKB, AXL, CSNK2A1, CYP1B1, ESR1, F3, FLT3, GRIK5, HCAR2, HSP90AB1, IGF1R, KDR, MCL1, MET, MMP9, PIK3CA, PIK3CB, PIM1, PPARG, PTGS2, PTPN1, SRC, TERT, TRPV1, XDH | 6.66536 |
[BP] GO:0042127 | regulation of cell proliferation | ADORA1, ADORA3, ADRA2A, AKR1B1, ALOX12, CDC25B, CHRM1, CSNK2A1, CYP1B1, DRD2, ESR1, ESRRA, F3, FABP3, FLT3, IGF1R, KDR, MMP12, MMP2, MMP9, PDE5A, PIM1, PPARG, PTGS1, PTGS2, SLC6A4, SRC, TERT, XDH | 6.6425 |
[BP] GO:0044237 | cellular metabolic process | ACHE, AKR1B1, AKR1B10, ALOX12, ALOX15, ALOX5, ALPL, AOX1, AURKB, AXL, CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CBR1, CDC25B, CES1, CES2, CHRM1, CHRM3, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, CYP3A4, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, FUT7, HSD17B1, HSD17B2, HSP90AA1, HSP90AB1, IGF1R, KCNH2, KDR, MAOB, MET, MMP1, MMP2, NQO2, NR3C1, PDE5A, PIK3CA, PIK3CB, PIM1, PPARA, PPARG, PTGS1, PTGS2, PTPN1, PTPRS, RORC, SLC6A4, SRC, TERT, TYR, XDH | 6.62963 |
[BP] GO:0071310 | cellular response to organic substance | ADRA2A, AKR1B1, ALOX15, ALPL, AXL, CYP1A1, CYP1B1, DRD1, ESR1, FABP4, FLT3, GRIK5, GRM5, HSP90AB1, IGF1R, KDR, MMP2, NR3C1, PIK3CA, PPARG, PTGS2, RORC, SLC6A4, SRC, TRPV1 | 6.62963 |
[BP] GO:0010941 | regulation of cell death | ADORA1, AKR1B1, ALOX12, AURKB, AXL, CSNK2A1, CYP1B1, ESR1, F3, FLT3, GRIK5, HCAR2, HSP90AB1, IGF1R, KDR, MCL1, MET, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PPARG, PTGS2, PTPN1, SRC, TERT, TRPV1, XDH | 6.62963 |
[BP] GO:0050896 | response to stimulus | ACHE, ADORA1, ADORA3, ADRA2A, AKR1B1, ALOX15, ALPL, AURKB, AXL, CA2, CA6, CA9, CES1, CHRM2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, ESR1, ESRRA, F3, FABP3, FABP4, FLT3, GRIK5, GRM1, GRM5, HSD17B2, HSP90AA1, HSP90AB1, IGF1R, KCNH2, KDR, MAOB, MCL1, MMP12, MMP2, MMP9, NR3C1, PIK3CA, PIK3CB, PPARA, PPARG, PTGS1, PTGS2, PTPN1, RORC, SLC6A2, SLC6A4, SRC, TERT, TRPV1, TYR | 6.42763 |
[BP] GO:0010646 | regulation of cell communication | ACHE, ADORA1, ADRA2A, AKR1B1, ALOX15, AURKB, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, ESR1, ESR2, F3, FLT3, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HSP90AB1, IGF1R, KDR, MCL1, MET, MMP12, MMP9, PDE5A, PIK3CA, PIK3CB, PPARG, PTGS2, PTPN1, PTPRS, SLC6A4, SRC, TERT, XDH | 6.28234 |
[BP] GO:0007215 | None | GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8 | 6.26342 |
[BP] GO:0071407 | cellular response to organic cyclic compound | ALPL, CYP1A1, CYP1B1, DRD1, ESR1, FLT3, HSP90AB1, NR3C1, PPARG, PTGS2, RORC, SLC6A4, SRC, TRPV1 | 6.25114 |
[BP] GO:0007268 | None | CHRM1, CHRM2, CHRM3, CHRM5, DRD1, DRD2, GRIA2, GRIK5, GRM1, GRM3, GRM5, SLC1A1, SLC6A2 | 6.23933 |
[BP] GO:0098916 | None | CHRM1, CHRM2, CHRM3, CHRM5, DRD1, DRD2, GRIA2, GRIK5, GRM1, GRM3, GRM5, SLC1A1, SLC6A2 | 6.23933 |
[BP] GO:0023051 | regulation of signaling | ACHE, ADORA1, ADRA2A, AKR1B1, ALOX15, AURKB, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, ESR1, ESR2, F3, FLT3, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HSP90AB1, IGF1R, KDR, MCL1, MET, MMP12, MMP9, PDE5A, PIK3CA, PIK3CB, PPARG, PTGS2, PTPN1, PTPRS, SLC6A4, SRC, TERT, XDH | 6.15039 |
[BP] GO:0042981 | regulation of apoptotic process | ADORA1, AKR1B1, ALOX12, AURKB, AXL, CSNK2A1, CYP1B1, ESR1, F3, FLT3, GRIK5, HCAR2, HSP90AB1, IGF1R, KDR, MCL1, MMP9, PIK3CA, PIK3CB, PIM1, PPARG, PTGS2, PTPN1, SRC, TERT, TRPV1, XDH | 6.15039 |
[BP] GO:0007197 | None | CHRM1, CHRM2, CHRM3, CHRM5 | 6.14571 |
[BP] GO:0099536 | None | CHRM1, CHRM2, CHRM3, CHRM5, DRD1, DRD2, GRIA2, GRIK5, GRM1, GRM3, GRM5, SLC1A1, SLC6A2 | 6.14571 |
[BP] GO:0099537 | None | CHRM1, CHRM2, CHRM3, CHRM5, DRD1, DRD2, GRIA2, GRIK5, GRM1, GRM3, GRM5, SLC1A1, SLC6A2 | 6.14571 |
[BP] GO:0050804 | modulation of chemical synaptic transmission | ACHE, ADORA1, CA2, CA7, DRD1, DRD2, GRIK5, GRM1, GRM3, GRM5, GRM8, PTGS2, SLC6A4 | 6.1211 |
[BP] GO:0099177 | regulation of trans-synaptic signaling | ACHE, ADORA1, CA2, CA7, DRD1, DRD2, GRIK5, GRM1, GRM3, GRM5, GRM8, PTGS2, SLC6A4 | 6.1211 |
[BP] GO:0042493 | response to drug | AKR1B1, AXL, CA9, CYP1A1, CYP1B1, DRD1, DRD2, FABP3, HSP90AB1, KCNH2, KDR, MAOB, NR3C1, PPARG, PTGS2, SLC6A2, SLC6A4, SRC, TRPV1 | 6.1211 |
[BP] GO:0032879 | regulation of localization | ACHE, ADORA1, ADORA3, ADRA2A, ALOX12, ALOX15, AXL, CA2, CA7, CHRM1, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, F3, GRIK5, GRM5, HCAR2, HSP90AB1, IGF1R, KCNH2, KDR, MAOB, MET, MMP12, MMP9, PIK3CB, PPARA, PPARG, PTGS2, PTPN1, SLC6A4, SRC, TERT, TRPV1 | 5.99713 |
[BP] GO:0019752 | carboxylic acid metabolic process | ALOX12, ALOX15, ALOX5, CBR1, CES1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, FABP3, PIM1, PPARA, PPARG, PTGS1, PTGS2, TYR | 5.82515 |
[BP] GO:0010035 | response to inorganic substance | AKR1B1, ALOX15, AXL, CA2, CYP1A1, CYP1A2, CYP1B1, DRD2, FABP4, KDR, MAOB, MMP9, PTGS2, SRC, TERT | 5.74823 |
[BP] GO:0007207 | None | CHRM1, CHRM2, CHRM3, CHRM5 | 5.74823 |
[BP] GO:0016098 | monoterpenoid metabolic process | CYP1A2, CYP2C19, CYP2D6, CYP3A4 | 5.74823 |
[BP] GO:0006820 | anion transport | CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, DRD2, FABP3, PPARA, PPARG, SLC1A1, TRPV1 | 5.65871 |
[BP] GO:0009987 | cellular process | ACHE, ADORA1, ADORA3, ADRA2A, AKR1B1, AKR1B10, ALOX12, ALOX15, ALOX5, ALPL, AOX1, AURKB, AXL, CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CBR1, CDC25B, CES1, CES2, CHRM1, CHRM2, CHRM3, CHRM5, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, CYP3A4, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, FUT7, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HSD17B1, HSD17B2, HSP90AA1, HSP90AB1, IGF1R, KCNH2, KDR, MAOB, MCL1, MET, MMP1, MMP12, MMP2, MMP9, NQO2, NR3C1, PDE5A, PIK3CA, PIK3CB, PIM1, PPARA, PPARG, PTGS1, PTGS2, PTPN1, PTPRS, RORC, SLC1A1, SLC6A2, SLC6A4, SRC, TERT, TRPV1, TYR, XDH | 5.62709 |
[BP] GO:0008610 | lipid biosynthetic process | ACHE, AKR1B1, ALOX12, ALOX15, CES1, CSNK2A1, CYP19A1, CYP1A1, CYP3A4, HSD11B1, HSD17B1, HSD17B2, PIK3CA, PIK3CB, PTGS1, PTGS2 | 5.57799 |
[BP] GO:0006811 | None | CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CHRM5, DRD1, DRD2, FABP3, GRIA2, GRIA4, GRIK5, KCNH2, PPARA, PPARG, SLC1A1, SLC6A2, SLC6A4, TRPV1 | 5.50396 |
[BP] GO:0051716 | cellular response to stimulus | ADRA2A, AKR1B1, ALOX15, ALPL, AURKB, AXL, CA2, CA9, CYP1A1, CYP1A2, CYP1B1, DRD1, ESR1, FABP4, FLT3, GRIK5, GRM1, GRM5, HSP90AB1, IGF1R, KCNH2, KDR, MCL1, MMP2, MMP9, NR3C1, PIK3CA, PPARG, PTGS2, PTPN1, RORC, SLC6A4, SRC, TERT, TRPV1 | 5.49977 |
[BP] GO:0030522 | intracellular receptor signaling pathway | ESR1, ESR2, ESRRA, ESRRB, NR3C1, PIM1, PPARA, PPARG, RORC, SRC | 5.48766 |
[BP] GO:0043401 | steroid hormone mediated signaling pathway | ESR1, ESR2, ESRRA, ESRRB, NR3C1, PPARA, PPARG, RORC, SRC | 5.48201 |
[BP] GO:0009698 | phenylpropanoid metabolic process | CYP1A1, CYP2A13, CYP2A6, CYP2D6 | 5.42557 |
[BP] GO:0009804 | coumarin metabolic process | CYP1A1, CYP2A13, CYP2A6, CYP2D6 | 5.42557 |
[BP] GO:0051173 | positive regulation of nitrogen compound metabolic process | ADORA1, ADRA2A, ALOX15, AURKB, CDC25B, CSNK2A1, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GRM1, GRM5, HSP90AA1, HSP90AB1, IGF1R, KDR, MAOB, MET, MMP12, MMP9, NR3C1, PDE5A, PIK3CA, PIK3CB, PPARA, PPARG, PTGS2, PTPN1, RORC, SRC, TERT, TRPV1, XDH | 5.41149 |
[BP] GO:0042445 | hormone metabolic process | ACHE, AKR1B1, CYP19A1, CYP1A1, CYP1B1, CYP3A4, ESR1, HSD11B1, HSD17B1, HSD17B2 | 5.28428 |
[BP] GO:1901701 | cellular response to oxygen-containing compound | AKR1B1, AXL, CYP1B1, DRD1, ESR1, GRIK5, GRM5, IGF1R, MMP2, MMP9, NR3C1, PIK3CA, PPARG, PTGS2, RORC, SLC6A4, SRC, TRPV1 | 5.27541 |
[BP] GO:0048878 | chemical homeostasis | ADRA2A, AKR1B1, ALOX12, CA12, CA2, CA7, DRD1, DRD2, ESR1, FABP3, FABP4, GRIK5, GRM1, GRM5, KCNH2, MET, PIK3CA, PIK3CB, PPARG, TRPV1 | 5.22272 |
[BP] GO:0032502 | developmental process | ACHE, ADORA1, AKR1B1, ALOX15, ALPL, AURKB, AXL, CA2, CA9, CBR1, CDC25B, CES1, CHRM1, CHRM2, CHRM3, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, ESR1, ESRRA, ESRRB, FABP4, FLT3, FUT7, HSD11B1, HSD17B2, HSP90AB1, KDR, MAOB, MCL1, MET, MMP2, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PPARG, PTGS2, PTPRS, RORC, SLC6A4, SRC, TERT, TYR | 5.20781 |
[BP] GO:0043436 | oxoacid metabolic process | ALOX12, ALOX15, ALOX5, CBR1, CES1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, FABP3, PIM1, PPARA, PPARG, PTGS1, PTGS2, TYR | 5.19969 |
[BP] GO:0007165 | signal transduction | ADORA1, ADORA3, ADRA2A, AKR1B1, AXL, CA1, CA2, CHRM1, CHRM2, CHRM3, CHRM5, CSNK2A1, CYP1B1, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HSP90AA1, HSP90AB1, IGF1R, KCNH2, KDR, MCL1, MET, MMP2, MMP9, NR3C1, PDE5A, PIK3CA, PIK3CB, PIM1, PPARA, PPARG, PTPN1, RORC, SRC, TRPV1 | 5.13478 |
[BP] GO:0009056 | catabolic process | ACHE, ADORA1, AKR1B10, AOX1, AURKB, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2C19, CYP2D6, CYP3A4, FABP3, FABP4, FUT7, HSP90AA1, MAOB, MMP1, MMP12, MMP2, MMP9, PDE5A, PIK3CB, SRC, XDH | 5.12414 |
[BP] GO:0007154 | None | ADORA1, AXL, CHRM1, CHRM2, CHRM3, CHRM5, DRD1, DRD2, ESR2, GRIA2, GRIK5, GRM1, GRM3, GRM5, PPARG, PTGS2, SLC1A1, SLC6A2, TRPV1 | 5.09257 |
[BP] GO:0006082 | organic acid metabolic process | ALOX12, ALOX15, ALOX5, CBR1, CES1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, FABP3, PIM1, PPARA, PPARG, PTGS1, PTGS2, TYR | 5.08706 |
[BP] GO:0017144 | drug metabolic process | ACHE, AKR1B1, AKR1B10, AOX1, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2C19, CYP2D6, CYP3A4, DRD1, DRD2, MAOB | 5.06875 |
[BP] GO:0009893 | positive regulation of metabolic process | ADORA1, ADRA2A, ALOX15, AURKB, CDC25B, CSNK2A1, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FLT3, GRM1, GRM5, HSP90AA1, HSP90AB1, IGF1R, KDR, MAOB, MET, MMP12, MMP9, NR3C1, PDE5A, PIK3CA, PIK3CB, PPARA, PPARG, PTGS2, PTPN1, RORC, SLC6A4, SRC, TERT, TRPV1, XDH | 5.02935 |
[BP] GO:0031325 | positive regulation of cellular metabolic process | ADORA1, ADRA2A, ALOX15, AURKB, CDC25B, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FLT3, GRM1, GRM5, HSP90AA1, HSP90AB1, IGF1R, KDR, MAOB, MET, MMP12, MMP9, NR3C1, PDE5A, PIK3CA, PIK3CB, PPARA, PPARG, PTGS2, PTPN1, RORC, SRC, TERT, TRPV1, XDH | 5.02742 |
[BP] GO:0051049 | regulation of transport | ACHE, ADORA1, ADRA2A, ALOX15, AXL, CA2, CA7, CHRM1, CYP19A1, DRD1, DRD2, GRIK5, GRM5, HCAR2, HSP90AB1, KCNH2, MAOB, MMP12, MMP9, PIK3CB, PPARA, PPARG, PTGS2, PTPN1, SLC6A4, SRC, TERT, TRPV1 | 5.02742 |
[BP] GO:0019220 | regulation of phosphate metabolic process | ADORA1, ADRA2A, ALOX15, CDC25B, CHRM5, DRD1, DRD2, ESRRB, FABP3, FABP4, FLT3, GRM1, GRM3, GRM5, GRM8, HSP90AB1, IGF1R, KDR, MMP9, PDE5A, PIK3CA, PIK3CB, PPARA, PTGS2, PTPN1, SRC, XDH | 5.02742 |
[BP] GO:1902533 | positive regulation of intracellular signal transduction | ADORA1, ADRA2A, AKR1B1, ALOX15, AXL, CYP1B1, DRD2, F3, FLT3, GRM1, KDR, MCL1, MET, PDE5A, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, XDH | 5.02679 |
[BP] GO:0009967 | positive regulation of signal transduction | ADORA1, ADRA2A, AKR1B1, ALOX15, AXL, CSNK2A1, CYP1B1, DRD2, F3, FLT3, GRM1, HSP90AB1, KDR, MCL1, MET, MMP12, MMP9, PDE5A, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, TERT, XDH | 4.98568 |
[BP] GO:0034754 | cellular hormone metabolic process | AKR1B1, CYP19A1, CYP1A1, CYP1B1, CYP3A4, ESR1, HSD17B1, HSD17B2 | 4.98069 |
[BP] GO:0051174 | regulation of phosphorus metabolic process | ADORA1, ADRA2A, ALOX15, CDC25B, CHRM5, DRD1, DRD2, ESRRB, FABP3, FABP4, FLT3, GRM1, GRM3, GRM5, GRM8, HSP90AB1, IGF1R, KDR, MMP9, PDE5A, PIK3CA, PIK3CB, PPARA, PTGS2, PTPN1, SRC, XDH | 4.97498 |
[BP] GO:0007196 | None | GRM1, GRM3, GRM5, GRM8 | 4.95177 |
[BP] GO:0010562 | positive regulation of phosphorus metabolic process | ADORA1, ADRA2A, ALOX15, CDC25B, DRD1, DRD2, ESRRB, FABP3, FLT3, GRM1, GRM5, HSP90AB1, KDR, MMP9, PDE5A, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, XDH | 4.87637 |
[BP] GO:0045937 | positive regulation of phosphate metabolic process | ADORA1, ADRA2A, ALOX15, CDC25B, DRD1, DRD2, ESRRB, FABP3, FLT3, GRM1, GRM5, HSP90AB1, KDR, MMP9, PDE5A, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, XDH | 4.87637 |
[BP] GO:0009636 | response to toxic substance | AKR1B1, ALPL, AXL, CES1, CYP1A1, CYP1B1, DRD1, DRD2, HSP90AA1, KDR, MAOB, SLC6A4, SRC | 4.83 |
[BP] GO:0097267 | omega-hydroxylase P450 pathway | CYP1A1, CYP1A2, CYP1B1, CYP2C19 | 4.74399 |
[BP] GO:0048871 | multicellular organismal homeostasis | ADORA1, AKR1B1, ALOX12, DRD1, DRD2, MET, PIK3CA, TRPV1 | 4.70566 |
[BP] GO:1901615 | organic hydroxy compound metabolic process | AKR1B1, AKR1B10, ALOX12, ALOX15, CES1, CYP19A1, CYP1A1, CYP1B1, CYP3A4, DRD1, DRD2, MAOB, TYR | 4.69287 |
[BP] GO:0051239 | regulation of multicellular organismal process | ADORA1, ADORA3, ADRA2A, ALOX12, AXL, CA2, CHRM1, CHRM2, CHRM3, CYP1B1, DRD2, ESR1, ESRRA, ESRRB, F3, GRM1, HCAR2, HSP90AB1, KCNH2, KDR, MET, MMP12, MMP9, PDE5A, PIK3CA, PIM1, PPARG, PTGS2, PTPRS, SLC1A1, SLC6A4, SRC, TERT, TRPV1, XDH | 4.69287 |
[BP] GO:0009755 | hormone-mediated signaling pathway | ESR1, ESR2, ESRRA, ESRRB, NR3C1, PPARA, PPARG, RORC, SRC | 4.6558 |
[BP] GO:0035690 | cellular response to drug | AKR1B1, AXL, CYP1B1, DRD1, HSP90AB1, KCNH2, KDR, NR3C1, PTGS2, SRC, TRPV1 | 4.63796 |
[BP] GO:1903522 | None | ADORA1, ADORA3, ADRA2A, CHRM1, CHRM2, CHRM3, DRD2, KCNH2, PDE5A, PTGS2, SLC1A1 | 4.59473 |
[BP] GO:0060548 | negative regulation of cell death | ADORA1, AKR1B1, ALOX12, AURKB, AXL, CSNK2A1, HSP90AB1, IGF1R, KDR, MCL1, MET, MMP9, PIK3CA, PIM1, PPARA, PTGS2, PTPN1, SRC, TERT | 4.55192 |
[BP] GO:0048523 | negative regulation of cellular process | ACHE, ADORA1, ADORA3, ADRA2A, AKR1B1, ALOX12, AURKB, AXL, CSNK2A1, CYP19A1, CYP1B1, CYP2D6, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, GRM3, GRM8, HSP90AB1, IGF1R, KCNH2, KDR, MAOB, MCL1, MET, MMP12, MMP9, NR3C1, PDE5A, PIK3CA, PIM1, PPARA, PPARG, PTGS2, PTPN1, PTPRS, RORC, SLC6A4, SRC, TERT, TRPV1, XDH | 4.51906 |
[BP] GO:0010817 | regulation of hormone levels | ACHE, ADORA1, ADRA2A, AKR1B1, CYP19A1, CYP1A1, CYP1B1, CYP3A4, DRD2, ESR1, HCAR2, HSD11B1, HSD17B1, HSD17B2 | 4.51031 |
[BP] GO:0051050 | positive regulation of transport | ACHE, ADORA1, ADRA2A, AXL, CA2, CHRM1, CYP19A1, DRD1, DRD2, HCAR2, HSP90AB1, KCNH2, MMP12, PPARG, PTGS2, SLC6A4, SRC, TERT, TRPV1 | 4.47982 |
[BP] GO:0030334 | regulation of cell migration | ADORA1, ADORA3, ADRA2A, ALOX12, CYP19A1, CYP1B1, DRD1, DRD2, F3, IGF1R, KDR, MET, MMP9, PPARG, PTGS2, SRC, TERT | 4.47256 |
[BP] GO:0019216 | regulation of lipid metabolic process | ADORA1, ADRA2A, CHRM5, CYP1A1, FABP3, FLT3, HCAR2, PPARA, PPARG, PTGS2, RORC, SRC | 4.46311 |
[BP] GO:0043069 | negative regulation of programmed cell death | ADORA1, AKR1B1, ALOX12, AURKB, AXL, CSNK2A1, HSP90AB1, IGF1R, KDR, MCL1, MET, MMP9, PIK3CA, PIM1, PTGS2, PTPN1, SRC, TERT | 4.46283 |
[BP] GO:0048856 | anatomical structure development | ACHE, ADORA1, AKR1B1, ALOX15, ALPL, AXL, CA2, CHRM1, CHRM2, CHRM3, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, ESR1, ESRRA, ESRRB, FLT3, HSD11B1, HSD17B2, HSP90AB1, KDR, MAOB, MCL1, MMP9, PIK3CA, PIM1, PPARA, PPARG, PTGS2, PTPRS, RORC, SRC, TYR | 4.43918 |
[BP] GO:0044057 | None | ADORA1, ADORA3, ADRA2A, CHRM1, CHRM2, CHRM3, DRD2, GRM1, HCAR2, KCNH2, PDE5A, PTGS2, SLC1A1, TRPV1 | 4.42675 |
[BP] GO:0015872 | None | CHRM5, DRD1, SLC6A2, SLC6A4 | 4.42675 |
[BP] GO:0042738 | exogenous drug catabolic process | CYP1A2, CYP2A6, CYP2C19, CYP3A4 | 4.42675 |
[BP] GO:0010604 | positive regulation of macromolecule metabolic process | ADORA1, ADRA2A, ALOX15, AURKB, CDC25B, CSNK2A1, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GRM1, GRM5, HSP90AA1, HSP90AB1, IGF1R, KDR, MET, MMP12, MMP9, NR3C1, PDE5A, PIK3CA, PIK3CB, PPARA, PPARG, PTGS2, PTPN1, RORC, SLC6A4, SRC, TERT, XDH | 4.42507 |
[BP] GO:0048513 | animal organ development | ACHE, AXL, CA2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, ESR1, ESRRA, ESRRB, FLT3, HSD11B1, HSD17B2, HSP90AB1, KDR, PIK3CA, PPARA, PPARG, PTPRS, SRC, TYR | 4.40157 |
[BP] GO:0008284 | positive regulation of cell proliferation | ADRA2A, AKR1B1, ALOX12, CDC25B, CHRM1, CSNK2A1, DRD2, ESR1, F3, FLT3, IGF1R, KDR, MMP12, MMP2, MMP9, PIM1, PTGS2, TERT | 4.36572 |
[BP] GO:0023052 | None | ADORA1, CHRM1, CHRM2, CHRM3, CHRM5, DRD1, DRD2, ESR2, GRIA2, GRIK5, GRM1, GRM3, GRM5, KCNH2, SLC1A1, SLC6A2 | 4.36429 |
[BP] GO:0042327 | positive regulation of phosphorylation | ADORA1, ADRA2A, ALOX15, CDC25B, DRD2, ESRRB, FLT3, GRM1, GRM5, HSP90AB1, KDR, MMP9, PDE5A, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, XDH | 4.33852 |
[BP] GO:0040012 | regulation of locomotion | ADORA1, ADORA3, ADRA2A, ALOX12, CHRM1, CYP19A1, CYP1B1, DRD1, DRD2, F3, IGF1R, KDR, MET, MMP9, PPARG, PTGS2, SRC, TERT | 4.33336 |
[BP] GO:0048584 | positive regulation of response to stimulus | ADORA1, ADRA2A, AKR1B1, ALOX15, AXL, CSNK2A1, CYP1B1, DRD2, ESRRA, F3, FABP4, FLT3, GRM1, HSP90AA1, HSP90AB1, KDR, MCL1, MET, MMP12, MMP2, MMP9, PDE5A, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, TERT, XDH | 4.26374 |
[BP] GO:0009628 | response to abiotic stimulus | ADORA1, AKR1B1, AURKB, CA2, CYP1A1, DRD1, DRD2, GRM1, HSP90AA1, HSP90AB1, MMP2, PPARA, PPARG, PTGS2, SLC6A4, SRC, TERT, TRPV1, TYR | 4.25868 |
[BP] GO:0007267 | None | ADORA1, CHRM1, CHRM2, CHRM3, CHRM5, DRD1, DRD2, ESR2, GRIA2, GRIK5, GRM1, GRM3, GRM5, SLC1A1, SLC6A2 | 4.23957 |
[BP] GO:0007216 | None | GRM1, GRM3, GRM5, GRM8 | 4.15816 |
[BP] GO:0048519 | negative regulation of biological process | ACHE, ADORA1, ADORA3, ADRA2A, AKR1B1, ALOX12, ALOX15, AURKB, AXL, CSNK2A1, CYP19A1, CYP1B1, CYP2D6, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, GRM3, GRM8, HCAR2, HSP90AB1, IGF1R, KCNH2, KDR, MAOB, MCL1, MET, MMP12, MMP9, NR3C1, PDE5A, PIK3CA, PIM1, PPARA, PPARG, PTGS2, PTPN1, PTPRS, RORC, SLC6A4, SRC, TERT, TRPV1, XDH | 4.15386 |
[BP] GO:0042446 | hormone biosynthetic process | AKR1B1, CYP19A1, CYP3A4, HSD11B1, HSD17B1, HSD17B2 | 4.14725 |
[BP] GO:0080134 | regulation of response to stress | ADORA1, ADRA2A, ALOX12, CYP19A1, DRD2, ESR1, F3, FABP4, HSP90AA1, HSP90AB1, IGF1R, MCL1, MET, MMP12, MMP2, PPARA, PPARG, PTGS2, PTPN1, PTPRS, SRC, TERT, XDH | 4.14725 |
[BP] GO:2000145 | regulation of cell motility | ADORA1, ADORA3, ADRA2A, ALOX12, CYP19A1, CYP1B1, DRD1, DRD2, F3, IGF1R, KDR, MET, MMP9, PPARG, PTGS2, SRC, TERT | 4.14528 |
[BP] GO:0032844 | regulation of homeostatic process | ADORA1, ADRA2A, AURKB, CA2, CA7, DRD1, DRD2, HCAR2, KDR, PIK3CB, PTGS2, SRC, TRPV1 | 4.10411 |
[BP] GO:0051937 | None | CHRM5, DRD1, SLC6A2, SLC6A4 | 4.03992 |
[BP] GO:0050805 | negative regulation of synaptic transmission | ACHE, ADORA1, DRD1, DRD2, PTGS2, SLC6A4 | 4.03385 |
[BP] GO:0006940 | None | ADORA1, ADRA2A, CHRM1, CHRM2, CHRM3, PTGS2 | 3.99593 |
[BP] GO:0001934 | positive regulation of protein phosphorylation | ADORA1, ADRA2A, ALOX15, CDC25B, DRD2, FLT3, GRM1, GRM5, HSP90AB1, KDR, MMP9, PDE5A, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, XDH | 3.98723 |
[BP] GO:0044238 | primary metabolic process | ACHE, ADORA1, AKR1B1, AKR1B10, ALOX12, ALOX15, ALOX5, ALPL, AOX1, AURKB, AXL, CBR1, CDC25B, CES1, CES2, CHRM1, CHRM3, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, CYP3A4, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, FUT7, HSD11B1, HSD17B1, HSD17B2, HSP90AA1, HSP90AB1, IGF1R, KCNH2, KDR, MET, MMP1, MMP12, MMP2, MMP9, NR3C1, PDE5A, PIK3CA, PIK3CB, PIM1, PPARA, PPARG, PTGS1, PTGS2, PTPN1, PTPRS, RORC, SRC, TERT, TRPV1, TYR, XDH | 3.9728 |
[BP] GO:0042325 | regulation of phosphorylation | ADORA1, ADRA2A, ALOX15, CDC25B, DRD1, DRD2, ESRRB, FABP4, FLT3, GRM1, GRM5, HSP90AB1, IGF1R, KDR, MMP9, PDE5A, PIK3CA, PIK3CB, PPARA, PTGS2, PTPN1, SRC, XDH | 3.95282 |
[BP] GO:0043066 | negative regulation of apoptotic process | ADORA1, AKR1B1, ALOX12, AURKB, AXL, CSNK2A1, HSP90AB1, IGF1R, KDR, MCL1, MMP9, PIK3CA, PIM1, PTGS2, PTPN1, SRC, TERT | 3.93794 |
[BP] GO:0007213 | None | CHRM1, CHRM2, CHRM3, CHRM5 | 3.93794 |
[BP] GO:0032225 | None | DRD1, DRD2, PTGS2, SLC6A4 | 3.93794 |
[BP] GO:0019372 | lipoxygenase pathway | ALOX12, ALOX15, ALOX5, PTGS2 | 3.93794 |
[BP] GO:0010243 | response to organonitrogen compound | AKR1B1, DRD1, DRD2, FABP3, FLT3, GRM5, HSP90AB1, IGF1R, MMP2, PPARA, PPARG, PTGS2, SLC6A4, SRC, TRPV1, TYR | 3.92951 |
[BP] GO:0006721 | terpenoid metabolic process | AKR1B10, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6, CYP3A4 | 3.92455 |
[BP] GO:0003018 | None | ADORA1, ADRA2A, CHRM1, CHRM3, DRD1, PTGS2, SLC6A4, SRC | 3.92455 |
[BP] GO:0046456 | icosanoid biosynthetic process | ALOX12, ALOX15, ALOX5, PTGS1, PTGS2 | 3.92455 |
[BP] GO:0007166 | cell surface receptor signaling pathway | ADORA1, ADORA3, AXL, CA1, CSNK2A1, DRD2, F3, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HSP90AA1, HSP90AB1, IGF1R, KDR, MCL1, MET, MMP2, MMP9, PIK3CA, PIK3CB, PTPN1, SRC, TRPV1 | 3.8376 |
[BP] GO:0006367 | transcription initiation from RNA polymerase II promoter | ESR1, ESR2, ESRRA, ESRRB, NR3C1, PPARA, PPARG, RORC | 3.83057 |
[BP] GO:0051347 | positive regulation of transferase activity | ADORA1, ADRA2A, AURKB, CDC25B, DRD2, FLT3, GRM1, GRM5, HSP90AA1, HSP90AB1, PDE5A, PIK3CA, PIK3CB, PTPN1, SRC | 3.80932 |
[BP] GO:0048010 | vascular endothelial growth factor receptor signaling pathway | AXL, HSP90AA1, KDR, PIK3CA, PIK3CB, SRC | 3.77024 |
[BP] GO:0045860 | positive regulation of protein kinase activity | ADORA1, ADRA2A, CDC25B, DRD2, FLT3, GRM1, GRM5, HSP90AB1, PDE5A, PIK3CA, PIK3CB, PTPN1, SRC | 3.77011 |
[BP] GO:0042737 | drug catabolic process | ACHE, CYP1A2, CYP2A6, CYP2C19, CYP2D6, CYP3A4, MAOB | 3.7586 |
[BP] GO:0051270 | regulation of cellular component movement | ADORA1, ADORA3, ADRA2A, ALOX12, CYP19A1, CYP1B1, DRD1, DRD2, F3, IGF1R, KDR, MET, MMP9, PPARG, PTGS2, SRC, TERT | 3.71253 |
[BP] GO:0070482 | response to oxygen levels | ADORA1, CYP1A1, DRD2, MMP2, PPARA, PPARG, PTGS2, SLC6A4, SRC, TERT | 3.70248 |
[BP] GO:1902531 | regulation of intracellular signal transduction | ADORA1, ADRA2A, AKR1B1, ALOX15, AURKB, AXL, CSNK2A1, CYP1B1, DRD2, ESR1, F3, FLT3, GRM1, IGF1R, KDR, MCL1, MET, MMP9, PDE5A, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, XDH | 3.67736 |
[BP] GO:0060078 | None | ADORA1, GRIA2, GRIA4, GRIK5, GRM5, TRPV1 | 3.61498 |
[BP] GO:0051338 | regulation of transferase activity | ADORA1, ADRA2A, AURKB, CDC25B, DRD2, FABP4, FLT3, GRM1, GRM5, HSP90AA1, HSP90AB1, IGF1R, PDE5A, PIK3CA, PIK3CB, PPARG, PTPN1, SRC | 3.60873 |
[BP] GO:2001300 | lipoxin metabolic process | ALOX12, ALOX15, ALOX5 | 3.60835 |
[BP] GO:0071704 | organic substance metabolic process | ACHE, ADORA1, AKR1B1, AKR1B10, ALOX12, ALOX15, ALOX5, ALPL, AOX1, AURKB, AXL, CBR1, CDC25B, CES1, CES2, CHRM1, CHRM3, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, CYP3A4, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, FUT7, HSD11B1, HSD17B1, HSD17B2, HSP90AA1, HSP90AB1, IGF1R, KCNH2, KDR, MAOB, MET, MMP1, MMP12, MMP2, MMP9, NR3C1, PDE5A, PIK3CA, PIK3CB, PIM1, PPARA, PPARG, PTGS1, PTGS2, PTPN1, PTPRS, RORC, SRC, TERT, TRPV1, TYR, XDH | 3.54538 |
[BP] GO:1901698 | response to nitrogen compound | AKR1B1, DRD1, DRD2, FABP3, FLT3, GRM5, HSP90AB1, IGF1R, MMP2, PPARA, PPARG, PTGS2, SLC6A4, SRC, TRPV1, TYR | 3.54122 |
[BP] GO:0097746 | None | ADORA1, ADRA2A, CHRM1, CHRM3, DRD1, PTGS2, SLC6A4 | 3.5391 |
[BP] GO:0035296 | None | ADORA1, ADRA2A, CHRM1, CHRM3, DRD1, PTGS2, SLC6A4 | 3.5391 |
[BP] GO:0048585 | negative regulation of response to stimulus | ADORA1, ADRA2A, ALOX12, ALOX15, CYP19A1, DRD1, DRD2, ESR1, ESR2, IGF1R, MCL1, MET, MMP12, MMP9, PPARA, PPARG, PTGS2, PTPN1, PTPRS, SRC, TERT, XDH | 3.52378 |
[BP] GO:0006720 | isoprenoid metabolic process | AKR1B10, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6, CYP3A4 | 3.5199 |
[BP] GO:0006694 | steroid biosynthetic process | AKR1B1, CES1, CYP19A1, CYP3A4, HSD11B1, HSD17B1, HSD17B2 | 3.49975 |
[BP] GO:0033674 | positive regulation of kinase activity | ADORA1, ADRA2A, CDC25B, DRD2, FLT3, GRM1, GRM5, HSP90AB1, PDE5A, PIK3CA, PIK3CB, PTPN1, SRC | 3.49975 |
[BP] GO:0015844 | None | CHRM5, DRD1, SLC6A2, SLC6A4 | 3.49153 |
[BP] GO:0001932 | regulation of protein phosphorylation | ADORA1, ADRA2A, ALOX15, CDC25B, DRD1, DRD2, FABP4, FLT3, GRM1, GRM5, HSP90AB1, IGF1R, KDR, MMP9, PDE5A, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, XDH | 3.47684 |
[BP] GO:0044092 | negative regulation of molecular function | ADORA3, ADRA2A, AURKB, CSNK2A1, CYP1B1, CYP2D6, DRD2, ESR1, FABP4, GRM3, IGF1R, MET, MMP9, PIM1, PPARA, PPARG, PTGS2, PTPN1, SRC | 3.39907 |
[BP] GO:0009820 | alkaloid metabolic process | CYP1A2, CYP2D6, CYP3A4 | 3.39907 |
[BP] GO:0010038 | response to metal ion | ALOX15, CA2, CYP1A1, CYP1A2, DRD2, FABP4, MAOB, MMP9, PTGS2, TERT | 3.38952 |
[BP] GO:0010648 | negative regulation of cell communication | ACHE, ADORA1, ADRA2A, DRD1, DRD2, ESR1, ESR2, IGF1R, MCL1, MET, MMP12, MMP9, PPARG, PTGS2, PTPN1, PTPRS, SLC6A4, SRC, TERT, XDH | 3.38917 |
[BP] GO:0050880 | None | ADORA1, ADRA2A, CHRM1, CHRM3, DRD1, PTGS2, SLC6A4 | 3.38811 |
[BP] GO:0050790 | regulation of catalytic activity | ADORA1, ADORA3, ADRA2A, AURKB, CDC25B, CSNK2A1, DRD1, DRD2, ESR1, F3, FABP4, FLT3, GRM1, GRM3, GRM5, HSP90AA1, HSP90AB1, IGF1R, MMP9, PDE5A, PIK3CA, PIK3CB, PPARG, PTGS2, PTPN1, SRC, TERT, XDH | 3.38355 |
[BP] GO:0051972 | regulation of telomerase activity | AURKB, HSP90AA1, HSP90AB1, PPARG, SRC | 3.3806 |
[BP] GO:0023057 | negative regulation of signaling | ACHE, ADORA1, ADRA2A, DRD1, DRD2, ESR1, ESR2, IGF1R, MCL1, MET, MMP12, MMP9, PPARG, PTGS2, PTPN1, PTPRS, SLC6A4, SRC, TERT, XDH | 3.37649 |
[BP] GO:0035150 | None | ADORA1, ADRA2A, CHRM1, CHRM3, DRD1, PTGS2, SLC6A4 | 3.37519 |
[BP] GO:0007186 | G-protein coupled receptor signaling pathway | ADORA1, ADORA3, ADRA2A, CA2, CHRM1, CHRM2, CHRM3, CHRM5, DRD1, DRD2, ESR1, GRM1, GRM3, GRM5, GRM8, HCAR2, PIK3CA, PIK3CB, PPARG, SRC | 3.37519 |
[BP] GO:0095500 | None | CHRM1, CHRM2, CHRM3, CHRM5 | 3.35747 |
[BP] GO:1903831 | None | CHRM1, CHRM2, CHRM3, CHRM5 | 3.35747 |
[BP] GO:0051240 | positive regulation of multicellular organismal process | ADRA2A, ALOX12, AXL, CA2, CHRM3, CYP1B1, DRD2, ESRRB, F3, HCAR2, KDR, MET, MMP12, MMP9, PDE5A, PIM1, PPARG, PTGS2, SLC1A1, SRC, TERT, TRPV1 | 3.34289 |
[BP] GO:0008210 | estrogen metabolic process | CYP19A1, CYP1B1, HSD17B1, HSD17B2 | 3.288 |
[BP] GO:1903409 | reactive oxygen species biosynthetic process | CYP1A1, CYP1A2, CYP1B1, MAOB | 3.288 |
[BP] GO:0001666 | response to hypoxia | ADORA1, CYP1A1, DRD2, MMP2, PPARA, PTGS2, SLC6A4, SRC, TERT | 3.28464 |
[BP] GO:0050665 | hydrogen peroxide biosynthetic process | CYP1A1, CYP1A2, MAOB | 3.23187 |
[BP] GO:0043271 | negative regulation of ion transport | ADORA1, ADRA2A, DRD2, KCNH2, MAOB, MMP9, PTGS2 | 3.23015 |
[BP] GO:0007169 | transmembrane receptor protein tyrosine kinase signaling pathway | AXL, FLT3, HSP90AA1, IGF1R, KDR, MET, MMP2, MMP9, PIK3CA, PIK3CB, PTPN1, SRC | 3.22148 |
[BP] GO:0071495 | cellular response to endogenous stimulus | ADRA2A, AKR1B1, DRD1, ESR1, FLT3, GRM5, IGF1R, MMP2, NR3C1, PPARG, PTGS2, SLC6A4, SRC, TRPV1 | 3.21111 |
[BP] GO:0032101 | regulation of response to external stimulus | ADORA1, ALOX12, CYP19A1, DRD1, DRD2, ESR1, F3, FABP4, KDR, MET, MMP12, PPARA, PPARG, PTGS2, PTPRS | 3.19584 |
[BP] GO:0036293 | response to decreased oxygen levels | ADORA1, CYP1A1, DRD2, MMP2, PPARA, PTGS2, SLC6A4, SRC, TERT | 3.19401 |
[BP] GO:0045859 | regulation of protein kinase activity | ADORA1, ADRA2A, CDC25B, DRD2, FABP4, FLT3, GRM1, GRM5, HSP90AB1, IGF1R, PDE5A, PIK3CA, PIK3CB, PTPN1, SRC | 3.16153 |
[BP] GO:0006352 | DNA-templated transcription, initiation | ESR1, ESR2, ESRRA, ESRRB, NR3C1, PPARA, PPARG, RORC | 3.14242 |
[BP] GO:0003013 | None | ADORA1, ADRA2A, CHRM1, CHRM3, DRD1, PTGS2, SLC6A4, SRC | 3.14242 |
[BP] GO:0065009 | regulation of molecular function | ADORA1, ADORA3, ADRA2A, AURKB, CDC25B, CSNK2A1, CYP1B1, CYP2D6, DRD1, DRD2, ESR1, ESR2, F3, FABP4, FLT3, GRM1, GRM3, GRM5, HSP90AA1, HSP90AB1, IGF1R, MET, MMP9, PDE5A, PIK3CA, PIK3CB, PIM1, PPARA, PPARG, PTGS2, PTPN1, SRC, TERT, TRPV1, XDH | 3.13743 |
[BP] GO:0043410 | positive regulation of MAPK cascade | ADORA1, ADRA2A, ALOX15, DRD2, FLT3, GRM1, KDR, PDE5A, PIK3CB, PTPN1, SRC, XDH | 3.13652 |
[BP] GO:0007271 | None | CHRM1, CHRM2, CHRM3, CHRM5 | 3.1094 |
[BP] GO:2000021 | regulation of ion homeostasis | ADORA1, CA2, CA7, DRD1, DRD2, KDR, SRC, TRPV1 | 3.10653 |
[BP] GO:0051234 | None | ACHE, ADORA1, ADRA2A, ALOX15, ALOX5, AXL, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CHRM1, CHRM3, CHRM5, DRD1, DRD2, FABP3, GRIA2, GRIA4, GRIK5, HSP90AA1, HSP90AB1, KCNH2, MCL1, MMP12, MMP9, PPARA, PPARG, SLC1A1, SLC6A2, SLC6A4, SRC, TERT, TRPV1, XDH | 3.09031 |
[BP] GO:0043269 | regulation of ion transport | ADORA1, ADRA2A, CA2, CA7, CHRM1, DRD1, DRD2, GRM5, KCNH2, MAOB, MMP9, PTGS2, SLC6A4 | 3.08888 |
[BP] GO:0051896 | regulation of protein kinase B signaling | AXL, DRD2, F3, MET, PIK3CA, PIK3CB, SRC, XDH | 3.06786 |
[BP] GO:0044093 | positive regulation of molecular function | ADORA1, ADRA2A, AURKB, CDC25B, DRD2, ESR1, ESR2, F3, FLT3, GRM1, GRM5, HSP90AA1, HSP90AB1, MET, MMP9, PDE5A, PIK3CA, PIK3CB, PPARG, PTPN1, SRC, TERT, XDH | 3.02952 |
[BP] GO:0051247 | positive regulation of protein metabolic process | ADORA1, ADRA2A, ALOX15, CDC25B, CSNK2A1, DRD2, ESR1, F3, FLT3, GRM1, GRM5, HSP90AB1, KDR, MMP9, PDE5A, PIK3CA, PIK3CB, PPARG, PTGS2, PTPN1, SRC, XDH | 3.02232 |
[BP] GO:0048511 | rhythmic process | AXL, CSNK2A1, DRD2, ESR1, PPARA, PPARG, RORC, SLC6A4, SRC | 3.00949 |
[BP] GO:0030335 | positive regulation of cell migration | ADRA2A, ALOX12, DRD1, F3, IGF1R, KDR, MET, MMP9, PTGS2, SRC, TERT | 3.00316 |
[BP] GO:0006636 | unsaturated fatty acid biosynthetic process | ALOX12, ALOX15, PTGS1, PTGS2 | 2.99944 |
[BP] GO:0048583 | regulation of response to stimulus | ADORA1, ADRA2A, AKR1B1, ALOX12, ALOX15, AURKB, AXL, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, ESR1, ESR2, ESRRA, F3, FABP4, FLT3, GRM1, HSP90AA1, HSP90AB1, IGF1R, KDR, MCL1, MET, MMP12, MMP2, MMP9, PDE5A, PIK3CA, PIK3CB, PPARA, PPARG, PTGS2, PTPN1, PTPRS, SRC, TERT, XDH | 2.97744 |
[BP] GO:0003008 | None | ADORA1, ADRA2A, AKR1B1, CHRM1, CHRM3, CHRM5, CYP1B1, DRD1, DRD2, GRM1, GRM5, GRM8, KCNH2, PDE5A, PIK3CA, PTGS2, SLC6A4, SRC, TRPV1, TYR | 2.97304 |
[BP] GO:0006810 | None | ACHE, ADORA1, ADRA2A, ALOX15, ALOX5, AXL, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CHRM1, CHRM3, CHRM5, DRD1, DRD2, FABP3, GRIA2, GRIA4, GRIK5, HSP90AA1, HSP90AB1, KCNH2, MCL1, MMP12, MMP9, PPARA, PPARG, SLC1A1, SLC6A2, SLC6A4, SRC, TRPV1, XDH | 2.96192 |
[BP] GO:2001225 | regulation of chloride transport | CA2, CA7, GRM5 | 2.95617 |
[BP] GO:0006937 | None | ADORA1, ADRA2A, CHRM1, CHRM2, CHRM3, PDE5A, PTGS2 | 2.91184 |
[BP] GO:0001659 | None | ADORA1, DRD1, DRD2, TRPV1 | 2.89905 |
[BP] GO:1901617 | organic hydroxy compound biosynthetic process | AKR1B1, ALOX12, ALOX15, CES1, CYP19A1, CYP3A4, TYR | 2.89905 |
[BP] GO:0022900 | electron transport chain | AKR1B1, AOX1, CYP19A1, CYP1A2, MAOB, NQO2, XDH | 2.89905 |
[BP] GO:0032270 | positive regulation of cellular protein metabolic process | ADORA1, ADRA2A, ALOX15, CDC25B, DRD2, ESR1, F3, FLT3, GRM1, GRM5, HSP90AB1, KDR, MMP9, PDE5A, PIK3CA, PIK3CB, PPARG, PTGS2, PTPN1, SRC, XDH | 2.8925 |
[BP] GO:0032846 | positive regulation of homeostatic process | AURKB, CA2, CA7, DRD1, DRD2, HCAR2, PIK3CB, PTGS2 | 2.88636 |
[BP] GO:2000147 | positive regulation of cell motility | ADRA2A, ALOX12, DRD1, F3, IGF1R, KDR, MET, MMP9, PTGS2, SRC, TERT | 2.88636 |
[BP] GO:0032228 | regulation of synaptic transmission, GABAergic | ADORA1, CA2, CA7, DRD2 | 2.8539 |
[BP] GO:0043549 | regulation of kinase activity | ADORA1, ADRA2A, CDC25B, DRD2, FABP4, FLT3, GRM1, GRM5, HSP90AB1, IGF1R, PDE5A, PIK3CA, PIK3CB, PTPN1, SRC | 2.84755 |
[BP] GO:0019371 | None | CBR1, PTGS1, PTGS2 | 2.84711 |
[BP] GO:0043085 | positive regulation of catalytic activity | ADORA1, ADRA2A, AURKB, CDC25B, DRD2, ESR1, F3, FLT3, GRM1, GRM5, HSP90AA1, HSP90AB1, PDE5A, PIK3CA, PIK3CB, PPARG, PTPN1, SRC, TERT, XDH | 2.84711 |
[BP] GO:0051179 | None | ACHE, ADORA1, ADRA2A, ALOX15, ALOX5, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CHRM1, CHRM3, CHRM5, DRD1, DRD2, ESR1, FABP3, GRIA2, GRIA4, GRIK5, HSP90AA1, HSP90AB1, KCNH2, MCL1, MMP12, MMP9, PPARA, PPARG, SLC1A1, SLC6A2, SLC6A4, SRC, TERT, TRPV1, XDH | 2.81339 |
[BP] GO:0008283 | cell proliferation | ACHE, AURKB, CHRM1, CHRM3, CHRM5, CYP1A1, ESR1, FLT3, MET, PIK3CB, PIM1, SRC, TYR | 2.8079 |
[BP] GO:1900542 | None | ADRA2A, DRD1, DRD2, ESRRB, GRM3, GRM8, PDE5A, PPARA | 2.79587 |
[BP] GO:0051272 | positive regulation of cellular component movement | ADRA2A, ALOX12, DRD1, F3, IGF1R, KDR, MET, MMP9, PTGS2, SRC, TERT | 2.79355 |
[BP] GO:0009892 | negative regulation of metabolic process | ADORA1, ADRA2A, AURKB, CSNK2A1, CYP2D6, DRD2, ESR1, ESR2, ESRRA, FABP4, GRM3, GRM8, HCAR2, HSP90AB1, IGF1R, KDR, MCL1, MET, MMP12, MMP9, NR3C1, PIK3CA, PPARA, PPARG, PTGS2, PTPN1, RORC, SRC, TERT, TRPV1, XDH | 2.79005 |
[BP] GO:0060079 | None | ADORA1, GRIA2, GRIA4, GRIK5, TRPV1 | 2.76382 |
[BP] GO:0006796 | phosphate-containing compound metabolic process | ACHE, ALOX15, ALPL, AURKB, AXL, CDC25B, CSNK2A1, DRD1, DRD2, FLT3, HSP90AA1, IGF1R, KCNH2, KDR, MET, PDE5A, PIK3CA, PIK3CB, PIM1, PTGS2, PTPN1, PTPRS, SRC, XDH | 2.76382 |
[BP] GO:0009115 | None | AOX1, XDH | 2.76382 |
[BP] GO:2001301 | lipoxin biosynthetic process | ALOX12, ALOX15 | 2.76382 |
[BP] GO:2001302 | lipoxin A4 metabolic process | ALOX12, ALOX15 | 2.76382 |
[BP] GO:2001303 | lipoxin A4 biosynthetic process | ALOX12, ALOX15 | 2.76382 |
[BP] GO:0070989 | oxidative demethylation | CYP1A2, CYP2D6, CYP3A4 | 2.75039 |
[BP] GO:0031401 | positive regulation of protein modification process | ADORA1, ADRA2A, ALOX15, CDC25B, DRD2, FLT3, GRM1, GRM5, HSP90AB1, KDR, MMP9, PDE5A, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, XDH | 2.74897 |
[BP] GO:0071417 | cellular response to organonitrogen compound | AKR1B1, DRD1, GRM5, IGF1R, MMP2, PPARG, PTGS2, SLC6A4, SRC, TRPV1 | 2.72841 |
[BP] GO:0006140 | None | ADRA2A, DRD1, DRD2, ESRRB, GRM3, GRM8, PDE5A, PPARA | 2.72841 |
[BP] GO:1900543 | None | ADRA2A, DRD2, GRM3, GRM8, PPARA | 2.72361 |
[BP] GO:0045980 | None | ADRA2A, DRD2, GRM3, GRM8, PPARA | 2.69679 |
[BP] GO:1901654 | None | AKR1B1, CA9, CSNK2A1, MAOB, NR3C1, PPARG, SRC | 2.69036 |
[BP] GO:0042391 | None | ADORA1, DRD1, GRIA2, GRIA4, GRIK5, GRM5, KCNH2, KDR, SRC, TRPV1 | 2.69036 |
[BP] GO:0040017 | positive regulation of locomotion | ADRA2A, ALOX12, DRD1, F3, IGF1R, KDR, MET, MMP9, PTGS2, SRC, TERT | 2.68472 |
[BP] GO:0050806 | positive regulation of synaptic transmission | ADORA1, CA2, CA7, DRD1, DRD2, PTGS2 | 2.67537 |
[BP] GO:0001101 | response to acid chemical | AKR1B1, FABP3, HSD17B2, KDR, MMP2, PPARG, PTGS2, SLC6A4, SRC | 2.66315 |
[BP] GO:0006703 | estrogen biosynthetic process | CYP19A1, HSD17B1, HSD17B2 | 2.65782 |
[BP] GO:0045834 | positive regulation of lipid metabolic process | FABP3, FLT3, PPARA, PPARG, PTGS2, SRC | 2.64292 |
[BP] GO:0031347 | regulation of defense response | ADORA1, CYP19A1, DRD2, ESR1, FABP4, HSP90AB1, MMP12, MMP2, PPARA, PPARG, PTGS2, PTPN1, PTPRS, SRC | 2.64292 |
[BP] GO:0097164 | None | ACHE, AKR1B1, AKR1B10, CSNK2A1, DRD1, DRD2, MAOB | 2.64072 |
[BP] GO:0071702 | None | ADORA1, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CHRM5, DRD1, DRD2, FABP3, HSP90AA1, MCL1, MMP12, PPARA, PPARG, SLC1A1, SLC6A2, SLC6A4, TRPV1 | 2.63991 |
[BP] GO:0048661 | positive regulation of smooth muscle cell proliferation | AKR1B1, MMP2, MMP9, PTGS2, TERT | 2.60159 |
[BP] GO:0018108 | peptidyl-tyrosine phosphorylation | AXL, FLT3, HSP90AA1, IGF1R, KDR, MET, SRC | 2.58707 |
[BP] GO:0060065 | uterus development | CYP19A1, ESR1, SRC | 2.56781 |
[BP] GO:0048660 | regulation of smooth muscle cell proliferation | AKR1B1, MMP2, MMP9, PPARG, PTGS2, TERT | 2.55638 |
[BP] GO:0018958 | None | AKR1B1, DRD1, DRD2, MAOB, TYR | 2.55355 |
[BP] GO:0018212 | peptidyl-tyrosine modification | AXL, FLT3, HSP90AA1, IGF1R, KDR, MET, SRC | 2.54804 |
[BP] GO:0031399 | regulation of protein modification process | ADORA1, ADRA2A, ALOX15, CDC25B, DRD1, DRD2, FABP4, FLT3, GRM1, GRM5, HSP90AA1, HSP90AB1, IGF1R, KDR, MMP9, PDE5A, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, XDH | 2.53215 |
[BP] GO:0043065 | positive regulation of apoptotic process | CYP1B1, F3, GRIK5, HCAR2, MCL1, MMP9, PIK3CB, PPARG, PTGS2, SRC, TRPV1, XDH | 2.51881 |
[BP] GO:1901570 | None | ALOX12, ALOX15, ALOX5, PTGS1, PTGS2 | 2.50819 |
[BP] GO:0043405 | regulation of MAP kinase activity | ADORA1, ADRA2A, FLT3, GRM1, IGF1R, PDE5A, PIK3CB, PTPN1, SRC | 2.50571 |
[BP] GO:0009895 | negative regulation of catabolic process | ADORA1, ADRA2A, HCAR2, HSP90AB1, MCL1, MET, PIK3CA, PPARA | 2.50129 |
[BP] GO:0007584 | response to nutrient | ALPL, CYP1A1, PPARG, PTGS2, SLC6A4, TRPV1, TYR | 2.50129 |
[BP] GO:1904407 | positive regulation of nitric oxide metabolic process | HSP90AA1, HSP90AB1, PTGS2, TRPV1 | 2.50129 |
[BP] GO:0045429 | positive regulation of nitric oxide biosynthetic process | HSP90AA1, HSP90AB1, PTGS2, TRPV1 | 2.50129 |
[BP] GO:0043406 | positive regulation of MAP kinase activity | ADORA1, ADRA2A, FLT3, GRM1, PDE5A, PIK3CB, PTPN1, SRC | 2.49482 |
[BP] GO:0003012 | None | ADORA1, CHRM3, DRD1, DRD2, KCNH2, PDE5A, PIK3CA, TRPV1 | 2.49482 |
[BP] GO:0043068 | positive regulation of programmed cell death | CYP1B1, F3, GRIK5, HCAR2, MCL1, MMP9, PIK3CB, PPARG, PTGS2, SRC, TRPV1, XDH | 2.48905 |
[BP] GO:0051098 | regulation of binding | AURKB, CYP2D6, HSP90AB1, MET, MMP9, PPARA, PPARG, SRC, TERT | 2.48624 |
[BP] GO:1901699 | cellular response to nitrogen compound | AKR1B1, DRD1, GRM5, IGF1R, MMP2, PPARG, PTGS2, SLC6A4, SRC, TRPV1 | 2.48541 |
[BP] GO:0002682 | regulation of immune system process | ADORA1, ALOX15, AXL, CA2, CYP19A1, DRD2, ESR1, ESRRA, HCAR2, HSP90AA1, HSP90AB1, MMP12, MMP2, PDE5A, PIK3CA, PIK3CB, PPARG, PTPN1, PTPRS, SRC | 2.48203 |
[BP] GO:0033273 | response to vitamin | ALPL, CYP1A1, PPARG, PTGS2, TYR | 2.47178 |
[BP] GO:0046777 | protein autophosphorylation | AURKB, CSNK2A1, FLT3, IGF1R, KDR, PIM1, SRC | 2.47178 |
[BP] GO:0043408 | regulation of MAPK cascade | ADORA1, ADRA2A, ALOX15, DRD2, FLT3, GRM1, IGF1R, KDR, PDE5A, PIK3CB, PTPN1, SRC, XDH | 2.47178 |
[BP] GO:0043268 | None | ADORA1, ADRA2A, DRD1, KCNH2 | 2.47178 |
[BP] GO:0019222 | regulation of metabolic process | ACHE, ADORA1, ADORA3, ADRA2A, ALOX15, AURKB, CA9, CDC25B, CHRM5, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, GRM1, GRM3, GRM5, GRM8, HCAR2, HSP90AA1, HSP90AB1, IGF1R, KDR, MAOB, MCL1, MET, MMP12, MMP9, NR3C1, PDE5A, PIK3CA, PIK3CB, PIM1, PPARA, PPARG, PTGS2, PTPN1, RORC, SLC6A4, SRC, TERT, TRPV1, XDH | 2.45782 |
[BP] GO:0044248 | cellular catabolic process | ACHE, AKR1B10, AOX1, AURKB, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2C19, CYP2D6, CYP3A4, FABP3, FABP4, HSP90AA1, MAOB, PDE5A, PIK3CB, SRC, XDH | 2.45765 |
[BP] GO:0016042 | lipid catabolic process | ADORA1, AKR1B10, CYP19A1, CYP1A2, CYP1B1, CYP3A4, FABP3, FABP4 | 2.44042 |
[BP] GO:1901652 | response to peptide | AKR1B1, FABP3, GRM5, IGF1R, PPARA, PPARG, PTGS2, SRC, TRPV1 | 2.44042 |
[BP] GO:0006584 | None | AKR1B1, DRD1, DRD2, MAOB | 2.43944 |
[BP] GO:0009712 | None | AKR1B1, DRD1, DRD2, MAOB | 2.43944 |
[BP] GO:0061098 | None | ADORA1, ADRA2A, GRM5, PTPN1 | 2.43944 |
[BP] GO:0009891 | positive regulation of biosynthetic process | AURKB, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, FABP3, HSP90AA1, HSP90AB1, IGF1R, KDR, MET, MMP12, NR3C1, PPARA, PPARG, PTGS2, RORC, SRC, TERT, TRPV1 | 2.42731 |
[BP] GO:0071902 | positive regulation of protein serine/threonine kinase activity | ADORA1, ADRA2A, FLT3, GRM1, HSP90AB1, PDE5A, PIK3CB, PTPN1, SRC | 2.42731 |
[BP] GO:2000811 | negative regulation of anoikis | MCL1, PIK3CA, SRC | 2.42584 |
[BP] GO:0030540 | female genitalia development | AXL, CYP19A1, ESR1 | 2.42584 |
[BP] GO:0044283 | None | AKR1B1, ALOX12, ALOX15, ALOX5, CES1, CYP19A1, CYP1A1, CYP3A4, PTGS1, PTGS2 | 2.41392 |
[BP] GO:0009966 | regulation of signal transduction | ADORA1, ADRA2A, AKR1B1, ALOX15, AURKB, AXL, CSNK2A1, CYP1B1, DRD2, ESR1, ESR2, F3, FLT3, GRM1, HSP90AB1, IGF1R, KDR, MCL1, MET, MMP12, MMP9, PDE5A, PIK3CA, PIK3CB, PPARG, PTGS2, PTPN1, PTPRS, SRC, TERT, XDH | 2.40911 |
[BP] GO:0030818 | None | ADRA2A, DRD2, GRM3, GRM8 | 2.40911 |
[BP] GO:0006793 | phosphorus metabolic process | ACHE, ALOX15, ALPL, AURKB, AXL, CDC25B, CSNK2A1, DRD1, DRD2, FLT3, HSP90AA1, IGF1R, KCNH2, KDR, MET, PDE5A, PIK3CA, PIK3CB, PIM1, PTGS2, PTPN1, PTPRS, SRC, XDH | 2.38832 |
[BP] GO:0099566 | None | GRM1, GRM5 | 2.38474 |
[BP] GO:0009822 | alkaloid catabolic process | CYP2D6, CYP3A4 | 2.38474 |
[BP] GO:0046110 | None | AOX1, XDH | 2.38474 |
[BP] GO:0032849 | positive regulation of cellular pH reduction | CA2, CA7 | 2.38474 |
[BP] GO:0032227 | negative regulation of synaptic transmission, dopaminergic | PTGS2, SLC6A4 | 2.38474 |
[BP] GO:0043393 | regulation of protein binding | AURKB, HSP90AB1, MET, MMP9, PPARA, SRC, TERT | 2.38389 |
[BP] GO:0031324 | negative regulation of cellular metabolic process | ADRA2A, AURKB, CSNK2A1, CYP2D6, DRD2, ESR1, ESR2, ESRRA, FABP4, GRM3, GRM8, HSP90AB1, IGF1R, MCL1, MET, MMP12, MMP9, NR3C1, PIK3CA, PPARA, PPARG, PTGS2, PTPN1, RORC, SRC, TERT, TRPV1, XDH | 2.37968 |
[BP] GO:0043281 | regulation of cysteine-type endopeptidase activity involved in apoptotic process | CSNK2A1, F3, MMP9, PPARG, PTGS2, SRC, XDH | 2.37366 |
[BP] GO:0032102 | negative regulation of response to external stimulus | ADORA1, ALOX12, CYP19A1, DRD1, DRD2, PPARA, PPARG, PTPRS | 2.37366 |
[BP] GO:0030799 | None | ADRA2A, DRD1, DRD2, GRM3, GRM8, PDE5A | 2.37156 |
[BP] GO:0001504 | None | SLC1A1, SLC6A2, SLC6A4 | 2.37156 |
[BP] GO:0065007 | biological regulation | ACHE, ADORA1, ADORA3, ADRA2A, AKR1B1, ALOX12, ALOX15, AURKB, AXL, CA1, CA12, CA2, CA7, CA9, CDC25B, CHRM1, CHRM2, CHRM3, CHRM5, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HSD11B1, HSD17B1, HSD17B2, HSP90AA1, HSP90AB1, IGF1R, KCNH2, KDR, MAOB, MCL1, MET, MMP1, MMP12, MMP2, MMP9, NR3C1, PDE5A, PIK3CA, PIK3CB, PIM1, PPARA, PPARG, PTGS1, PTGS2, PTPN1, PTPRS, RORC, SLC1A1, SLC6A2, SLC6A4, SRC, TERT, TRPV1, XDH | 2.36147 |
[BP] GO:0030803 | None | ADRA2A, DRD2, GRM3, GRM8 | 2.35846 |
[BP] GO:0006950 | response to stress | ACHE, ADORA1, ADORA3, AKR1B1, ALOX15, AXL, CA2, CA9, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, HSP90AA1, HSP90AB1, MCL1, MMP2, MMP9, PIK3CA, PIK3CB, PPARA, PPARG, PTGS1, PTGS2, PTPN1, SLC6A2, SLC6A4, SRC, TERT, TRPV1 | 2.33264 |
[BP] GO:0051588 | None | DRD1, DRD2, GRIK5, MAOB, SLC6A4 | 2.32993 |
[BP] GO:2000379 | positive regulation of reactive oxygen species metabolic process | HSP90AA1, HSP90AB1, PTGS2, TRPV1, XDH | 2.32993 |
[BP] GO:0008150 | biological_process | ACHE, ADORA1, ADORA3, ADRA2A, AKR1B1, AKR1B10, ALOX12, ALOX15, ALOX5, ALPL, AOX1, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CBR1, CDC25B, CES1, CES2, CHRM1, CHRM2, CHRM3, CHRM5, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, CYP3A4, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, FUT7, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HSD11B1, HSD17B1, HSD17B2, HSP90AA1, HSP90AB1, IGF1R, KCNH2, KDR, MAOB, MCL1, MET, MMP1, MMP12, MMP2, MMP9, NQO2, NR3C1, PDE5A, PIK3CA, PIK3CB, PIM1, PPARA, PPARG, PTGS1, PTGS2, PTPN1, PTPRS, RORC, SLC1A1, SLC6A2, SLC6A4, SRC, TERT, TRPV1, TYR, XDH | 2.30642 |
[BP] GO:0007004 | None | HSP90AA1, HSP90AB1, TERT | 2.30483 |
[BP] GO:0090066 | None | ADORA1, ADRA2A, ALOX15, CHRM1, CHRM3, DRD1, HSP90AB1, PTGS2, SLC6A4 | 2.30419 |
[BP] GO:0030815 | None | ADRA2A, DRD2, GRM3, GRM8 | 2.29831 |
[BP] GO:0006939 | None | CHRM3, DRD1, DRD2, TRPV1 | 2.29831 |
[BP] GO:0015893 | None | CA2, CHRM5, DRD1, SLC1A1, SLC6A2, SLC6A4 | 2.29413 |
[BP] GO:0071248 | cellular response to metal ion | ALOX15, CYP1A1, CYP1A2, FABP4, MMP9, PTGS2 | 2.29413 |
[BP] GO:0008217 | None | ADORA1, DRD2, PPARA, PPARG, PTGS1, PTGS2 | 2.27906 |
[BP] GO:1900372 | None | ADRA2A, DRD2, GRM3, GRM8 | 2.27036 |
[BP] GO:0030809 | None | ADRA2A, DRD2, GRM3, GRM8 | 2.27036 |
[BP] GO:0010942 | positive regulation of cell death | CYP1B1, F3, GRIK5, HCAR2, MCL1, MMP9, PIK3CB, PPARG, PTGS2, SRC, TRPV1, XDH | 2.25202 |
[BP] GO:0030800 | None | ADRA2A, DRD2, GRM3, GRM8 | 2.24181 |
[BP] GO:0030100 | regulation of endocytosis | ALOX15, AXL, DRD2, PIK3CB, PPARG, PTPN1, SRC | 2.24181 |
[BP] GO:0048545 | response to steroid hormone | ALPL, CA2, FLT3, MAOB, NR3C1, PTGS2, SRC | 2.24181 |
[BP] GO:2001243 | negative regulation of intrinsic apoptotic signaling pathway | MCL1, MMP9, PTGS2, PTPN1, SRC | 2.24181 |
[BP] GO:0051897 | positive regulation of protein kinase B signaling | AXL, F3, MET, PIK3CA, PIK3CB, SRC | 2.24181 |
[BP] GO:0045766 | positive regulation of angiogenesis | ALOX12, CYP1B1, F3, KDR, PTGS2, TERT | 2.21235 |
[BP] GO:0050801 | ion homeostasis | CA12, CA2, CA7, DRD1, DRD2, ESR1, FABP3, GRM1, GRM5, KCNH2, PIK3CB, TRPV1 | 2.21235 |
[BP] GO:0051047 | None | ACHE, ADORA1, CYP19A1, DRD2, HCAR2, MMP12, SLC6A4, SRC, TRPV1 | 2.21228 |
[BP] GO:0031960 | response to corticosteroid | ALPL, FLT3, MAOB, NR3C1, PTGS2, SRC | 2.1993 |
[BP] GO:0007167 | enzyme linked receptor protein signaling pathway | AXL, FLT3, HSP90AA1, IGF1R, KDR, MET, MMP2, MMP9, PIK3CA, PIK3CB, PTPN1, SRC | 2.18931 |
[BP] GO:0030817 | None | ADRA2A, DRD1, DRD2, GRM3, GRM8 | 2.18931 |
[BP] GO:0043266 | None | ADORA1, ADRA2A, DRD1, DRD2, KCNH2 | 2.18931 |
[BP] GO:0042752 | None | ADORA1, DRD2, PPARA, PPARG, RORC | 2.18931 |
[BP] GO:1903428 | positive regulation of reactive oxygen species biosynthetic process | HSP90AA1, HSP90AB1, PTGS2, TRPV1 | 2.18931 |
[BP] GO:0050994 | None | ADORA1, ADRA2A, HCAR2, PPARA | 2.18931 |
[BP] GO:0015696 | None | CHRM5, DRD1, SLC6A2, SLC6A4 | 2.15887 |
[BP] GO:0090257 | None | ADORA1, ADRA2A, CHRM1, CHRM2, CHRM3, PDE5A, PTGS2 | 2.15078 |
[BP] GO:1905323 | None | HSP90AA1, HSP90AB1 | 2.15078 |
[BP] GO:0033031 | positive regulation of neutrophil apoptotic process | HCAR2, PIK3CB | 2.15078 |
[BP] GO:0006145 | None | AOX1, XDH | 2.15078 |
[BP] GO:0032847 | regulation of cellular pH reduction | CA2, CA7 | 2.15078 |
[BP] GO:0018894 | dibenzo-p-dioxin metabolic process | CYP1A1, CYP1A2 | 2.15078 |
[BP] GO:0071498 | cellular response to fluid shear stress | CA2, PTGS2, SRC | 2.1442 |
[BP] GO:0072593 | reactive oxygen species metabolic process | ALOX12, CYP1A1, CYP1A2, CYP1B1, MAOB | 2.12573 |
[BP] GO:0050878 | regulation of body fluid levels | ADORA1, AKR1B1, ALOX12, CHRM1, CHRM3, DRD2, F3, MET, XDH | 2.08985 |
[BP] GO:1904707 | positive regulation of vascular smooth muscle cell proliferation | MMP2, MMP9, TERT | 2.08943 |
[BP] GO:0030520 | intracellular estrogen receptor signaling pathway | ESR1, ESR2, SRC | 2.08943 |
[BP] GO:0050995 | None | ADORA1, ADRA2A, HCAR2 | 2.08943 |
[BP] GO:0032147 | activation of protein kinase activity | ADORA1, ADRA2A, DRD2, GRM1, PIK3CA, PIK3CB, PTPN1, SRC | 2.08943 |
[BP] GO:2000116 | regulation of cysteine-type endopeptidase activity | CSNK2A1, F3, MMP9, PPARG, PTGS2, SRC, XDH | 2.07805 |
[BP] GO:2000278 | regulation of DNA biosynthetic process | AURKB, HSP90AA1, HSP90AB1, PPARG, SRC | 2.07518 |
[BP] GO:0031323 | regulation of cellular metabolic process | ACHE, ADORA1, ADORA3, ADRA2A, ALOX15, AURKB, CA9, CDC25B, CHRM5, CSNK2A1, CYP1B1, CYP2D6, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, GRM1, GRM3, GRM5, GRM8, HSP90AA1, HSP90AB1, IGF1R, KDR, MAOB, MCL1, MET, MMP12, MMP9, NR3C1, PDE5A, PIK3CA, PIK3CB, PIM1, PPARA, PPARG, PTGS2, PTPN1, RORC, SRC, TERT, TRPV1, XDH | 2.07518 |
[BP] GO:0008016 | None | ADORA1, ADORA3, CHRM2, DRD2, KCNH2, PDE5A, SLC1A1 | 2.07054 |
[BP] GO:0046486 | glycerolipid metabolic process | ACHE, ALOX15, CSNK2A1, DRD2, FABP3, FABP4, MET, PIK3CA, PIK3CB | 2.06708 |
[BP] GO:0045428 | regulation of nitric oxide biosynthetic process | HSP90AA1, HSP90AB1, PTGS2, TRPV1 | 2.06243 |
[BP] GO:0043270 | None | ADORA1, ADRA2A, CHRM1, DRD1, DRD2, KCNH2, SLC6A4 | 2.06212 |
[BP] GO:0044236 | multicellular organism metabolic process | MMP1, MMP12, MMP2, MMP9, TRPV1 | 2.06151 |
[BP] GO:0002683 | negative regulation of immune system process | ADORA1, ALOX15, AXL, CYP19A1, DRD2, MMP12, PDE5A, PPARG, PTPRS | 2.05484 |
[BP] GO:0003006 | developmental process involved in reproduction | ALPL, AXL, CDC25B, CYP19A1, ESR1, ESRRB, HSD17B2, HSP90AB1, PPARG, PTGS2, SRC | 2.05124 |
[BP] GO:0051953 | None | ADORA1, ADRA2A, DRD2 | 2.04461 |
[BP] GO:2000209 | regulation of anoikis | MCL1, PIK3CA, SRC | 2.04461 |
[BP] GO:0009404 | toxin metabolic process | CYP1A1, CYP1A2, CYP1B1 | 2.04461 |
[BP] GO:2000377 | regulation of reactive oxygen species metabolic process | CYP1B1, HSP90AA1, HSP90AB1, PTGS2, TRPV1, XDH | 2.03993 |
[BP] GO:0071900 | regulation of protein serine/threonine kinase activity | ADORA1, ADRA2A, FLT3, GRM1, HSP90AB1, IGF1R, PDE5A, PIK3CB, PTPN1, SRC | 2.03879 |
[BP] GO:0034614 | cellular response to reactive oxygen species | AKR1B1, AXL, CYP1B1, MMP9, SRC | 2.03182 |
[BP] GO:1901575 | None | ACHE, ADORA1, AKR1B10, AOX1, AURKB, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2D6, CYP3A4, FABP3, FABP4, FUT7, HSP90AA1, MAOB, PDE5A, XDH | 2.02263 |
[BP] GO:0030258 | lipid modification | ALOX12, CYP1A1, CYP3A4, MET, PIK3CA, PIK3CB, PPARG | 2.01788 |
[BP] GO:0070988 | demethylation | CYP1A1, CYP1A2, CYP2D6, CYP3A4 | 2.01772 |
[BP] GO:0031348 | negative regulation of defense response | ADORA1, CYP19A1, DRD2, MMP12, PPARA, PPARG | 2.01772 |
[BP] GO:0006468 | protein phosphorylation | AURKB, AXL, CDC25B, CSNK2A1, DRD1, FLT3, HSP90AA1, IGF1R, KCNH2, KDR, MET, PIK3CA, PIM1, SRC | 2.00743 |
[BP] GO:0071241 | cellular response to inorganic substance | ALOX15, CYP1A1, CYP1A2, FABP4, MMP9, PTGS2 | 2.00583 |
[BP] GO:0030168 | platelet activation | ADRA2A, AXL, PIK3CA, PIK3CB, SRC | 2.00096 |
[CC] GO:0098590 | plasma membrane region | ADORA1, ADRA2A, CA2, CA4, CA9, CHRM1, CHRM2, CHRM3, CHRM5, DRD1, DRD2, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HSP90AA1, HSP90AB1, MET, PTGS2, SLC1A1, SRC, TRPV1 | 8.37317 |
[CC] GO:0005886 | plasma membrane | ACHE, ADORA1, ADORA3, ADRA2A, ALOX12, ALOX15, ALPL, AXL, CA12, CA14, CA2, CA4, CA9, CHRM1, CHRM2, CHRM3, CHRM5, CSNK2A1, DRD1, DRD2, ESR1, F3, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HSP90AA1, IGF1R, KCNH2, KDR, MET, MMP2, PIK3CA, PIK3CB, PIM1, PTPN1, PTPRS, SLC1A1, SLC6A2, SLC6A4, SRC, TERT, TRPV1 | 5.91085 |
[CC] GO:0044459 | plasma membrane part | ADORA1, ADORA3, ADRA2A, ALOX15, AXL, CA2, CA4, CA9, CHRM1, CHRM2, CHRM3, CHRM5, DRD1, DRD2, F3, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HSP90AA1, HSP90AB1, IGF1R, KCNH2, KDR, MET, PTGS2, PTPRS, SLC1A1, SLC6A2, SLC6A4, SRC, TRPV1 | 5.85545 |
[CC] GO:0016020 | membrane | ACHE, ADORA1, ADORA3, ADRA2A, ALOX12, ALOX15, ALOX5, ALPL, AXL, CA12, CA14, CA2, CA4, CA9, CHRM1, CHRM2, CHRM3, CHRM5, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, CYP3A4, DRD1, DRD2, ESR1, F3, FLT3, FUT7, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HSD11B1, HSD17B2, HSP90AA1, HSP90AB1, IGF1R, KCNH2, KDR, MAOB, MCL1, MET, MMP2, PIK3CA, PIK3CB, PIM1, PTGS1, PTGS2, PTPN1, PTPRS, SLC1A1, SLC6A2, SLC6A4, SRC, TERT, TRPV1, TYR | 5.84236 |
[CC] GO:0031226 | intrinsic component of plasma membrane | ADORA1, ADORA3, ADRA2A, AXL, CA4, CHRM1, CHRM2, CHRM3, CHRM5, DRD1, DRD2, F3, FLT3, GRIA2, GRM1, GRM3, GRM5, GRM8, IGF1R, KDR, MET, PTPRS, SLC1A1, SLC6A2, SLC6A4, TRPV1 | 5.78065 |
[CC] GO:0044425 | membrane part | ACHE, ADORA1, ADORA3, ADRA2A, ALOX15, ALPL, AXL, CA12, CA14, CA2, CA4, CA9, CHRM1, CHRM2, CHRM3, CHRM5, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, CYP3A4, DRD1, DRD2, ESR1, F3, FLT3, FUT7, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HSD11B1, HSD17B2, HSP90AA1, HSP90AB1, IGF1R, KCNH2, KDR, MAOB, MCL1, MET, PIK3CA, PIK3CB, PTGS1, PTGS2, PTPN1, PTPRS, SLC1A1, SLC6A2, SLC6A4, SRC, TRPV1, TYR | 5.76221 |
[CC] GO:0044456 | None | ACHE, ADORA1, CHRM1, CHRM2, CHRM3, CHRM5, DRD2, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, PTPRS, SLC6A4, SRC, TRPV1 | 5.74823 |
[CC] GO:0097060 | None | CHRM1, CHRM2, CHRM3, CHRM5, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, TRPV1 | 5.43783 |
[CC] GO:0005887 | integral component of plasma membrane | ADORA1, ADORA3, ADRA2A, AXL, CHRM1, CHRM2, CHRM3, CHRM5, DRD1, DRD2, FLT3, GRIA2, GRM1, GRM3, GRM5, GRM8, IGF1R, KDR, MET, PTPRS, SLC1A1, SLC6A2, SLC6A4, TRPV1 | 4.97498 |
[CC] GO:0043005 | None | ADORA1, CA2, CHRM1, CHRM2, CHRM3, DRD2, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, PTGS2, PTPRS, SLC6A2, SLC6A4, SRC | 4.33913 |
[CC] GO:0045211 | None | CHRM1, CHRM2, CHRM3, CHRM5, GRIA2, GRIA4, GRIK5, GRM3, TRPV1 | 3.92047 |
[CC] GO:0044463 | None | ADORA1, AKR1B1, CA4, CA9, CHRM1, CHRM2, CHRM3, DRD1, DRD2, GRIA2, GRIA4, GRIK5, GRM3, HSP90AA1, HSP90AB1, PTGS1, SRC, TRPV1 | 3.39907 |
[CC] GO:0120038 | None | ADORA1, AKR1B1, CA4, CA9, CHRM1, CHRM2, CHRM3, DRD1, DRD2, GRIA2, GRIA4, GRIK5, GRM3, HSP90AA1, HSP90AB1, PTGS1, SRC, TRPV1 | 3.39907 |
[CC] GO:0044444 | cytoplasmic part | ACHE, ADORA1, AKR1B1, AKR1B10, ALOX12, ALOX15, ALOX5, AOX1, AURKB, CA1, CA2, CA4, CA5A, CA5B, CA7, CBR1, CDC25B, CES1, CES2, CHRM2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, CYP3A4, DRD1, DRD2, ESR1, ESR2, FABP3, FABP4, FLT3, FUT7, GRIA2, GRIA4, GRIK5, HSD11B1, HSD17B1, HSD17B2, HSP90AA1, HSP90AB1, KCNH2, KDR, MAOB, MCL1, MMP2, MMP9, NQO2, NR3C1, PDE5A, PIK3CA, PIK3CB, PIM1, PPARG, PTGS1, PTGS2, PTPN1, PTPRS, SLC6A4, SRC, TERT, TRPV1, TYR, XDH | 3.33925 |
[CC] GO:0120025 | None | ADORA1, AKR1B1, CA2, CHRM1, CHRM2, CHRM3, DRD1, DRD2, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, PIK3CA, PTGS2, PTPRS, SLC6A2, SLC6A4, SRC | 3.288 |
[CC] GO:0014069 | None | ADORA1, CHRM1, DRD2, GRIK5, GRM1, GRM3, GRM5, SRC | 3.23366 |
[CC] GO:0099572 | None | ADORA1, CHRM1, DRD2, GRIK5, GRM1, GRM3, GRM5, SRC | 3.23366 |
[CC] GO:0042995 | cell projection | ADORA1, AKR1B1, CA2, CHRM1, CHRM2, CHRM3, DRD1, DRD2, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, PIK3CA, PTGS2, PTPRS, SLC6A2, SLC6A4, SRC | 2.97899 |
[CC] GO:0042734 | None | GRIK5, GRM1, GRM3, GRM5, GRM8 | 2.95316 |
[CC] GO:0097458 | None | ADORA1, CA2, CHRM1, CHRM2, CHRM3, DRD2, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, PTGS1, PTGS2, PTPRS, SLC6A2, SLC6A4, SRC, TRPV1 | 2.92348 |
[CC] GO:0044432 | endoplasmic reticulum part | CES1, CES2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, CYP3A4, DRD1, FLT3, GRIA2, HSD11B1, HSD17B2, PTGS1, PTGS2, PTPN1 | 2.88374 |
[CC] GO:0098793 | None | ADORA1, CHRM1, CHRM2, CHRM3, DRD2, GRIK5, SLC6A4 | 2.84711 |
[CC] GO:0031253 | None | ADORA1, CA4, CA9, DRD1, DRD2, HSP90AA1, HSP90AB1, SRC, TRPV1 | 2.72556 |
[CC] GO:0016323 | basolateral plasma membrane | ADORA1, ADRA2A, CA2, CA4, CA9, CHRM3, HSP90AB1 | 2.58707 |
[CC] GO:0005789 | endoplasmic reticulum membrane | CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, CYP3A4, DRD1, GRIA2, HSD11B1, HSD17B2, PTGS1, PTGS2 | 2.52327 |
[CC] GO:0044464 | cell part | ACHE, ADORA1, ADORA3, ADRA2A, AKR1B1, AKR1B10, ALOX12, ALOX15, ALOX5, ALPL, AOX1, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA7, CA9, CBR1, CDC25B, CES1, CES2, CHRM1, CHRM2, CHRM3, CHRM5, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, CYP3A4, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, FUT7, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HSD11B1, HSD17B1, HSD17B2, HSP90AA1, HSP90AB1, IGF1R, KCNH2, KDR, MAOB, MCL1, MET, MMP12, MMP2, MMP9, NQO2, NR3C1, PDE5A, PIK3CA, PIK3CB, PIM1, PPARA, PPARG, PTGS1, PTGS2, PTPN1, PTPRS, RORC, SLC1A1, SLC6A2, SLC6A4, SRC, TERT, TRPV1, TYR, XDH | 2.13172 |
[CC] GO:0043679 | None | CHRM1, CHRM2, CHRM3, DRD2 | 2.11157 |
[MF] GO:0046914 | transition metal ion binding | ALOX12, ALOX15, ALOX5, AOX1, CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, CYP3A4, ESR1, ESR2, ESRRA, ESRRB, MMP1, MMP12, MMP2, MMP9, NQO2, NR3C1, PIM1, PPARA, PPARG, PTPN1, RORC, TYR, XDH | 19.1871 |
[MF] GO:0004089 | carbonate dehydratase activity | CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9 | 15.7404 |
[MF] GO:0043167 | ion binding | ACHE, ALOX12, ALOX15, ALOX5, ALPL, AOX1, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CHRM3, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, CYP3A4, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, HSD17B1, HSP90AA1, HSP90AB1, IGF1R, KDR, MAOB, MET, MMP1, MMP12, MMP2, MMP9, NQO2, NR3C1, PDE5A, PIK3CA, PIK3CB, PIM1, PPARA, PPARG, PTGS1, PTGS2, PTPN1, PTPRS, RORC, SLC1A1, SLC6A2, SLC6A4, SRC, TERT, TRPV1, TYR, XDH | 12.8902 |
[MF] GO:0003824 | catalytic activity | ACHE, ADORA1, AKR1B1, AKR1B10, ALOX12, ALOX15, ALOX5, ALPL, AOX1, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CBR1, CDC25B, CES1, CES2, CHRM1, CHRM3, CHRM5, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, CYP3A4, F3, FLT3, FUT7, HSD11B1, HSD17B1, HSD17B2, HSP90AA1, IGF1R, KCNH2, KDR, MAOB, MET, MMP1, MMP12, MMP2, MMP9, NQO2, PDE5A, PIK3CA, PIK3CB, PIM1, PTGS1, PTGS2, PTPN1, PTPRS, SRC, TERT, TYR, XDH | 11.0856 |
[MF] GO:0038023 | signaling receptor activity | ADORA1, ADORA3, ADRA2A, AXL, CHRM1, CHRM2, CHRM3, CHRM5, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, IGF1R, KCNH2, KDR, MET, NR3C1, PPARA, PPARG, RORC, TRPV1 | 10.9026 |
[MF] GO:0016491 | oxidoreductase activity | AKR1B1, AKR1B10, ALOX12, ALOX15, ALOX5, AOX1, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, CYP3A4, HSD11B1, HSD17B1, HSD17B2, MAOB, NQO2, PTGS1, PTGS2, TYR, XDH | 10.7463 |
[MF] GO:0005506 | iron ion binding | ALOX12, ALOX15, ALOX5, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, CYP3A4, XDH | 10.2552 |
[MF] GO:0016836 | hydro-lyase activity | CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9 | 9.91929 |
[MF] GO:0043169 | cation binding | ACHE, ALOX12, ALOX15, ALOX5, ALPL, AOX1, AURKB, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CHRM3, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, CYP3A4, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, MMP1, MMP12, MMP2, MMP9, NQO2, NR3C1, PDE5A, PIM1, PPARA, PPARG, PTGS1, PTGS2, PTPN1, RORC, SLC1A1, SLC6A2, SLC6A4, TERT, TRPV1, TYR, XDH | 9.77217 |
[MF] GO:0004872 | receptor activity | ADORA1, ADORA3, ADRA2A, AXL, CHRM1, CHRM2, CHRM3, CHRM5, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, IGF1R, KCNH2, KDR, MET, NR3C1, PPARA, PPARG, RORC, TRPV1 | 9.77217 |
[MF] GO:0016712 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen | CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, CYP3A4 | 9.52106 |
[MF] GO:0060089 | molecular transducer activity | ADORA1, ADORA3, ADRA2A, AXL, CHRM1, CHRM2, CHRM3, CHRM5, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, IGF1R, KCNH2, KDR, MET, NR3C1, PPARA, PPARG, RORC, TRPV1 | 9.41827 |
[MF] GO:0020037 | heme binding | CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, CYP3A4, PTGS1, PTGS2, SRC | 8.94854 |
[MF] GO:0004871 | signal transducer activity | ADORA1, ADORA3, ADRA2A, AXL, CHRM1, CHRM2, CHRM3, CHRM5, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, IGF1R, KCNH2, KDR, MET, NR3C1, PPARA, PPARG, RORC, TRPV1 | 8.67757 |
[MF] GO:0016835 | carbon-oxygen lyase activity | CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9 | 8.64828 |
[MF] GO:0046906 | tetrapyrrole binding | CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, CYP3A4, PTGS1, PTGS2, SRC | 8.60796 |
[MF] GO:0030594 | None | CHRM1, CHRM2, CHRM3, CHRM5, DRD1, DRD2, GRIA2, GRIA4, GRIK5, GRM1, GRM5 | 8.42739 |
[MF] GO:0008270 | zinc ion binding | CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, ESR1, ESR2, ESRRA, ESRRB, MMP1, MMP12, MMP2, MMP9, NQO2, NR3C1, PPARA, PPARG, PTPN1, RORC | 8.37317 |
[MF] GO:0070330 | aromatase activity | CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2D6, CYP3A4 | 8.13573 |
[MF] GO:0016705 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen | CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, CYP3A4, PTGS1, PTGS2, TYR | 8.07523 |
[MF] GO:0008144 | drug binding | ACHE, AURKB, AXL, CHRM1, CHRM2, CHRM3, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2C19, CYP2D6, CYP3A4, DRD1, DRD2, FLT3, HSP90AA1, HSP90AB1, IGF1R, KDR, MET, NQO2, PIK3CA, PIK3CB, PIM1, PPARA, PPARG, SLC6A4, SRC, TRPV1 | 7.97198 |
[MF] GO:0046872 | metal ion binding | ALOX12, ALOX15, ALOX5, ALPL, AOX1, AURKB, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, CYP3A4, ESR1, ESR2, ESRRA, ESRRB, MMP1, MMP12, MMP2, MMP9, NQO2, NR3C1, PDE5A, PIM1, PPARA, PPARG, PTGS1, PTGS2, PTPN1, RORC, SLC1A1, SLC6A2, SLC6A4, TERT, TRPV1, TYR, XDH | 7.83883 |
[MF] GO:0004497 | monooxygenase activity | CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, CYP3A4, TYR | 7.73726 |
[MF] GO:0008066 | None | GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8 | 7.66995 |
[MF] GO:0019825 | oxygen binding | CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2C19, CYP2D6, CYP3A4 | 7.66836 |
[MF] GO:0048037 | cofactor binding | AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, CYP3A4, HSD17B1, MAOB, NQO2, PTGS1, PTGS2, SRC, XDH | 7.07654 |
[MF] GO:0008395 | steroid hydroxylase activity | CYP19A1, CYP1A1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, CYP3A4 | 6.98627 |
[MF] GO:0003707 | steroid hormone receptor activity | ESR1, ESR2, ESRRA, ESRRB, NR3C1, PPARA, PPARG, RORC | 6.7908 |
[MF] GO:0099600 | transmembrane receptor activity | ADORA1, ADORA3, ADRA2A, AXL, CHRM1, CHRM2, CHRM3, CHRM5, DRD1, DRD2, F3, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, IGF1R, KDR, MET, PPARG, TRPV1 | 6.39878 |
[MF] GO:0004888 | transmembrane signaling receptor activity | ADORA1, ADORA3, ADRA2A, AXL, CHRM1, CHRM2, CHRM3, CHRM5, DRD1, DRD2, F3, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, IGF1R, KDR, MET, PPARG, TRPV1 | 6.39878 |
[MF] GO:0016907 | None | CHRM1, CHRM2, CHRM3, CHRM5 | 6.14571 |
[MF] GO:0098531 | transcription factor activity, direct ligand regulated sequence-specific DNA binding | ESR1, ESR2, ESRRA, ESRRB, PPARA, PPARG, RORC | 5.99713 |
[MF] GO:0004879 | nuclear receptor activity | ESR1, ESR2, ESRRA, ESRRB, PPARA, PPARG, RORC | 5.99713 |
[MF] GO:0005496 | steroid binding | CYP3A4, ESR1, ESR2, ESRRA, ESRRB, HSD17B1, NR3C1, RORC | 5.65871 |
[MF] GO:0016829 | lyase activity | CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9 | 5.30296 |
[MF] GO:0042802 | identical protein binding | ACHE, ADRA2A, AOX1, CSNK2A1, DRD2, ESR1, ESR2, FLT3, GRIK5, HSP90AA1, HSP90AB1, IGF1R, KCNH2, KDR, MAOB, MCL1, MET, MMP9, NQO2, PPARG, PTGS2, SLC6A4, TERT, TRPV1, TYR, XDH | 4.9994 |
[MF] GO:0008289 | lipid binding | ALOX15, AXL, CYP3A4, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, HSD17B1, NR3C1, PPARA, PPARG, RORC, TRPV1 | 4.51492 |
[MF] GO:0008227 | None | ADRA2A, CHRM1, CHRM2, CHRM3, CHRM5, DRD2 | 4.30689 |
[MF] GO:0016614 | oxidoreductase activity, acting on CH-OH group of donors | AKR1B1, AKR1B10, AOX1, CBR1, HSD11B1, HSD17B1, HSD17B2, XDH | 4.30246 |
[MF] GO:0009055 | electron transfer activity | AKR1B1, AOX1, CYP19A1, CYP1A2, MAOB, NQO2, XDH | 3.90386 |
[MF] GO:0015464 | None | CHRM1, CHRM2, CHRM3, CHRM5 | 3.74464 |
[MF] GO:0042803 | protein homodimerization activity | ACHE, ADRA2A, AOX1, DRD2, FLT3, HSP90AA1, HSP90AB1, KCNH2, MAOB, MCL1, NQO2, PTGS2, SLC6A4, TERT, TYR, XDH | 3.71836 |
[MF] GO:0042562 | hormone binding | ACHE, CHRM3, HSD17B1, IGF1R, NQO2, NR3C1 | 3.39907 |
[MF] GO:0030235 | nitric-oxide synthase regulator activity | ESR1, HSP90AA1, HSP90AB1 | 3.39907 |
[MF] GO:0044877 | macromolecular complex binding | ACHE, ADORA1, ADRA2A, CSNK2A1, ESRRB, FLT3, HSP90AA1, HSP90AB1, IGF1R, KDR, MMP12, MMP9, PIM1, PPARA, PTPN1, SLC6A4, SRC | 3.21632 |
[MF] GO:0016702 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen | ALOX12, ALOX15, ALOX5, PTGS2 | 3.16371 |
[MF] GO:0032403 | protein complex binding | ACHE, ADORA1, ADRA2A, ESRRB, FLT3, HSP90AA1, HSP90AB1, IGF1R, KDR, MMP12, MMP9, PPARA, PTPN1, SLC6A4, SRC | 3.14054 |
[MF] GO:0016701 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen | ALOX12, ALOX15, ALOX5, PTGS2 | 3.1094 |
[MF] GO:0016725 | oxidoreductase activity, acting on CH or CH2 groups | CYP1A2, CYP3A4, XDH | 3.08888 |
[MF] GO:0046983 | protein dimerization activity | ACHE, ADORA1, ADRA2A, AOX1, AXL, DRD2, FLT3, HSP90AA1, HSP90AB1, KCNH2, MAOB, MCL1, NQO2, PPARG, PTGS2, SLC6A4, TERT, TYR, XDH | 3.01476 |
[MF] GO:0004714 | transmembrane receptor protein tyrosine kinase activity | AXL, FLT3, IGF1R, KDR, MET | 2.95316 |
[MF] GO:0004629 | None | ADORA1, CHRM1, CHRM3, CHRM5 | 2.95167 |
[MF] GO:0099094 | None | GRIA2, GRIA4, GRIK5, KCNH2, TRPV1 | 2.86923 |
[MF] GO:0043560 | insulin receptor substrate binding | IGF1R, PIK3CA, PIK3CB | 2.84711 |
[MF] GO:0016788 | None | ACHE, ADORA1, ALPL, CA1, CA2, CDC25B, CES1, CES2, CHRM1, CHRM3, CHRM5, PDE5A, PTPN1, PTPRS | 2.8079 |
[MF] GO:0004666 | prostaglandin-endoperoxide synthase activity | PTGS1, PTGS2 | 2.76382 |
[MF] GO:0038052 | RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding | ESR1, ESR2 | 2.76382 |
[MF] GO:0047977 | hepoxilin-epoxide hydrolase activity | ALOX12, ALOX15 | 2.76382 |
[MF] GO:0008389 | None | CYP2A13, CYP2A6 | 2.76382 |
[MF] GO:0004930 | None | ADORA1, ADORA3, ADRA2A, CHRM1, CHRM2, CHRM3, CHRM5, DRD1, DRD2, GRM1, GRM3, GRM5, GRM8, HCAR2, PPARG | 2.75039 |
[MF] GO:0016616 | oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor | AKR1B1, AKR1B10, CBR1, HSD11B1, HSD17B1, HSD17B2 | 2.70948 |
[MF] GO:0070405 | ammonium ion binding | ACHE, CHRM3, DRD1, DRD2, SLC6A4 | 2.67446 |
[MF] GO:0004713 | protein tyrosine kinase activity | AXL, FLT3, HSP90AA1, IGF1R, KDR, MET, SRC | 2.65203 |
[MF] GO:0099528 | None | CHRM1, CHRM2, CHRM3, CHRM5 | 2.61193 |
[MF] GO:0019199 | transmembrane receptor protein kinase activity | AXL, FLT3, IGF1R, KDR, MET | 2.53071 |
[MF] GO:0016903 | None | AKR1B1, AKR1B10, AOX1, XDH | 2.40911 |
[MF] GO:0050473 | arachidonate 15-lipoxygenase activity | ALOX15, PTGS2 | 2.38474 |
[MF] GO:0070576 | vitamin D 24-hydroxylase activity | CYP1A1, CYP3A4 | 2.38474 |
[MF] GO:0004052 | arachidonate 12-lipoxygenase activity | ALOX12, ALOX15 | 2.38474 |
[MF] GO:0005330 | None | SLC6A2, SLC6A4 | 2.38474 |
[MF] GO:0051120 | hepoxilin A3 synthase activity | ALOX12, ALOX15 | 2.38474 |
[MF] GO:0099583 | None | GRM1, GRM5 | 2.38474 |
[MF] GO:0047374 | None | CES1, CES2 | 2.38474 |
[MF] GO:0008392 | None | CYP2A13, CYP2A6, CYP2C19 | 2.37156 |
[MF] GO:0008391 | None | CYP2A13, CYP2A6, CYP2C19 | 2.37156 |
[MF] GO:0051213 | dioxygenase activity | ALOX12, ALOX15, ALOX5, PTGS1, PTGS2 | 2.32993 |
[MF] GO:0042578 | None | ADORA1, ALPL, CDC25B, CHRM1, CHRM3, CHRM5, PDE5A, PTPN1, PTPRS | 2.32684 |
[MF] GO:0008081 | None | ADORA1, CHRM1, CHRM3, CHRM5, PDE5A | 2.30925 |
[MF] GO:0005231 | None | GRIA2, GRIA4, GRIK5, TRPV1 | 2.29831 |
[MF] GO:0003674 | molecular_function | ACHE, ADORA1, ADORA3, ADRA2A, AKR1B1, AKR1B10, ALOX12, ALOX15, ALOX5, ALPL, AOX1, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CBR1, CDC25B, CES1, CES2, CHRM1, CHRM2, CHRM3, CHRM5, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, CYP3A4, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, FUT7, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HSD11B1, HSD17B1, HSD17B2, HSP90AA1, HSP90AB1, IGF1R, KCNH2, KDR, MAOB, MCL1, MET, MMP1, MMP12, MMP2, MMP9, NQO2, NR3C1, PDE5A, PIK3CA, PIK3CB, PIM1, PPARA, PPARG, PTGS1, PTGS2, PTPN1, PTPRS, RORC, SLC1A1, SLC6A2, SLC6A4, SRC, TERT, TRPV1, TYR, XDH | 2.29749 |
[MF] GO:0004672 | protein kinase activity | AURKB, AXL, CSNK2A1, FLT3, HSP90AA1, IGF1R, KCNH2, KDR, MET, PIK3CA, PIM1, SRC | 2.29546 |
[MF] GO:0004970 | None | GRIA2, GRIA4, GRIK5 | 2.24656 |
[MF] GO:0005234 | None | GRIA2, GRIA4, GRIK5 | 2.24656 |
[MF] GO:1901338 | None | ADRA2A, DRD1, DRD2 | 2.18931 |
[MF] GO:0001223 | transcription coactivator binding | ESR1, PPARA, TERT | 2.18931 |
[MF] GO:0016773 | phosphotransferase activity, alcohol group as acceptor | AURKB, AXL, CSNK2A1, FLT3, HSP90AA1, IGF1R, KCNH2, KDR, MET, PIK3CA, PIK3CB, PIM1, SRC | 2.16933 |
[MF] GO:0019899 | enzyme binding | ADRA2A, AURKB, CDC25B, CYP1A1, CYP1A2, CYP2A6, CYP2C19, CYP3A4, ESR1, ESR2, ESRRB, F3, GRM5, HSP90AA1, HSP90AB1, KCNH2, MET, NR3C1, PPARA, PPARG, PTGS2, PTPN1, SLC6A4, SRC | 2.15078 |
[MF] GO:0034056 | estrogen response element binding | ESR1, ESR2 | 2.15078 |
[MF] GO:0034875 | caffeine oxidase activity | CYP1A2, CYP3A4 | 2.15078 |
[MF] GO:0004971 | None | GRIA2, GRIA4 | 2.15078 |
[MF] GO:0032795 | None | ADORA1, ADRA2A | 2.15078 |
[MF] GO:0033695 | oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor | CYP1A2, CYP3A4 | 2.15078 |
[MF] GO:0031072 | heat shock protein binding | ADORA1, CSNK2A1, HSP90AB1, KDR, NR3C1 | 2.07518 |
[MF] GO:0001047 | None | ESR1, ESR2, ESRRB, MMP12, NR3C1, PPARG | 2.05022 |
KEGG Pathway ID | Enriched Genes | Log10 Adjusted P-value |
---|---|---|
Nitrogen metabolism_Homo sapiens_hsa00910 | CA12, CA1, CA5B, CA5A, CA2, CA4, CA7, CA6, CA9, CA14 | 16.8874 |
Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | CHRM2, GRIA2, CHRM3, CHRM1, GRIK5, CHRM5, TRPV1, NR3C1, GRM1, ADRA2A, GRM3, GRM5, ADORA3, GRM8, ADORA1, DRD1, DRD2, GRIA4 | 13.0464 |
Estrogen signaling pathway_Homo sapiens_hsa04915 | HSP90AA1, HSP90AB1, PIK3CA, SRC, MMP2, PIK3CB, MMP9, ESR1, GRM1, ESR2 | 8.7254 |
Chemical carcinogenesis_Homo sapiens_hsa05204 | HSD11B1, CBR1, CYP2A6, CYP2A13, CYP1A2, CYP1A1, CYP1B1, PTGS2, CYP3A4, CYP2C19 | 9.4337 |
Ovarian steroidogenesis_Homo sapiens_hsa04913 | ALOX5, HSD17B1, HSD17B2, CYP1A1, CYP1B1, PTGS2, CYP19A1, IGF1R | 8.5664 |
Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | HSD11B1, CBR1, CYP2A6, CYP2A13, CYP2D6, CYP1A2, CYP1A1, CYP1B1, CYP3A4 | 8.6238 |
Metabolic pathways_Homo sapiens_hsa01100 | CBR1, MAOB, ALOX15, AKR1B1, ALOX12, PTGS2, TYR, CYP3A4, CYP2C19, CYP19A1, PTGS1, HSD11B1, CYP2A6, FUT7, AKR1B10, ALOX5, HSD17B1, HSD17B2, CYP1A2, CYP1A1, AOX1, ALPL, XDH, CES1 | 7.2402 |
cAMP signaling pathway_Homo sapiens_hsa04024 | CHRM2, HCAR2, GRIA2, CHRM1, PIK3CA, ADORA1, PIK3CB, DRD1, DRD2, PPARA, GRIA4 | 7.2402 |
Steroid hormone biosynthesis_Homo sapiens_hsa00140 | HSD11B1, HSD17B1, HSD17B2, CYP1A2, CYP1A1, CYP1B1, CYP3A4, CYP19A1 | 8.0942 |
Serotonergic synapse_Homo sapiens_hsa04726 | MAOB, CYP2D6, ALOX5, ALOX15, ALOX12, PTGS2, CYP2C19, PTGS1, SLC6A4 | 7.2386 |
Arachidonic acid metabolism_Homo sapiens_hsa00590 | CBR1, ALOX5, ALOX15, ALOX12, PTGS2, CYP2C19, PTGS1 | 6.5379 |
Glutamatergic synapse_Homo sapiens_hsa04724 | GRM3, GRIA2, GRM5, GRIK5, GRM8, SLC1A1, GRM1, GRIA4 | 6.0003 |
Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | CYP2A6, MAOB, CYP2D6, CYP1A2, AOX1, CYP3A4, CYP2C19 | 6.2463 |
Pathways in cancer_Homo sapiens_hsa05200 | HSP90AA1, HSP90AB1, PIK3CA, FLT3, MMP1, MMP2, PPARG, PIK3CB, PTGS2, MMP9, MET, IGF1R | 5.2983 |
Proteoglycans in cancer_Homo sapiens_hsa05205 | PIK3CA, SRC, MMP2, KDR, PIK3CB, MMP9, MET, ESR1, IGF1R | 5.2082 |
Cholinergic synapse_Homo sapiens_hsa04725 | CHRM2, ACHE, CHRM3, CHRM1, PIK3CA, CHRM5, PIK3CB | 4.9952 |
Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | FABP4, PIK3CA, ADORA1, PIK3CB, PTGS2, PTGS1 | 5.467 |
PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | CHRM2, HSP90AA1, HSP90AB1, CHRM1, PIK3CA, KDR, PIK3CB, MET, MCL1, IGF1R | 4.361 |
Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | HSP90AA1, HSP90AB1, PIK3CA, PIK3CB, CDC25B, IGF1R | 4.2421 |
Calcium signaling pathway_Homo sapiens_hsa04020 | CHRM2, CHRM3, GRM5, CHRM1, CHRM5, DRD1, GRM1 | 3.817 |
Tryptophan metabolism_Homo sapiens_hsa00380 | MAOB, CYP1A2, CYP1A1, AOX1, CYP1B1 | 4.9248 |
VEGF signaling pathway_Homo sapiens_hsa04370 | PIK3CA, SRC, KDR, PIK3CB, PTGS2 | 4.1223 |
Cocaine addiction_Homo sapiens_hsa05030 | GRM3, GRIA2, MAOB, DRD1, DRD2 | 4.521 |
Drug metabolism - other enzymes_Homo sapiens_hsa00983 | CYP2A6, CYP3A4, XDH, CES2, CES1 | 4.6383 |
Prolactin signaling pathway_Homo sapiens_hsa04917 | PIK3CA, SRC, PIK3CB, ESR1, ESR2 | 3.8182 |
Rap1 signaling pathway_Homo sapiens_hsa04015 | PIK3CA, SRC, KDR, PIK3CB, DRD2, MET, IGF1R | 3.4603 |
Phospholipase D signaling pathway_Homo sapiens_hsa04072 | GRM3, GRM5, PIK3CA, GRM8, PIK3CB, GRM1 | 3.4603 |
Retinol metabolism_Homo sapiens_hsa00830 | CYP2A6, CYP1A2, CYP1A1, AOX1, CYP3A4 | 4.0034 |
Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | CHRM2, CHRM3, CHRM1, PIK3CA, SRC, CHRM5, PIK3CB | 3.434 |
MicroRNAs in cancer_Homo sapiens_hsa05206 | PIK3CA, PIM1, CYP1B1, PTGS2, MMP9, MET, CDC25B, MCL1 | 3.371 |
Prostate cancer_Homo sapiens_hsa05215 | HSP90AA1, HSP90AB1, PIK3CA, PIK3CB, IGF1R | 3.4603 |
Adherens junction_Homo sapiens_hsa04520 | PTPN1, CSNK2A1, SRC, MET, IGF1R | 3.7902 |
PPAR signaling pathway_Homo sapiens_hsa03320 | FABP3, FABP4, MMP1, PPARG, PPARA | 3.8925 |
AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | PIK3CA, MMP2, PIM1, PIK3CB, F3 | 3.2678 |
Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | PIK3CA, SRC, ALOX12, PIK3CB, TRPV1 | 3.3073 |
Gap junction_Homo sapiens_hsa04540 | GRM5, SRC, DRD1, DRD2, GRM1 | 3.4603 |
cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | PIK3CA, ADORA3, ADORA1, PDE5A, PIK3CB, ADRA2A | 3.1911 |
Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | GRIA2, GRM5, PTGS2, GRM1, GRIA4 | 3.2678 |
Focal adhesion_Homo sapiens_hsa04510 | PIK3CA, SRC, KDR, PIK3CB, MET, IGF1R | 2.806 |
Dopaminergic synapse_Homo sapiens_hsa04728 | GRIA2, MAOB, DRD1, DRD2, GRIA4 | 2.8333 |
Jak-STAT signaling pathway_Homo sapiens_hsa04630 | PIK3CA, PIM1, AOX1, PIK3CB, MCL1 | 2.4703 |
Bladder cancer_Homo sapiens_hsa05219 | SRC, MMP1, MMP2, MMP9 | 3.6144 |
Amphetamine addiction_Homo sapiens_hsa05031 | GRIA2, MAOB, DRD1, GRIA4 | 2.9289 |
Melanoma_Homo sapiens_hsa05218 | PIK3CA, PIK3CB, MET, IGF1R | 2.8419 |
Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | FLT3, PPARG, MMP9, MET, IGF1R | 2.2366 |
Central carbon metabolism in cancer_Homo sapiens_hsa05230 | PIK3CA, FLT3, PIK3CB, MET | 2.9289 |
Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | PIK3CA, PPARG, PIK3CB, IGF1R | 2.4362 |
Acute myeloid leukemia_Homo sapiens_hsa05221 | PIK3CA, FLT3, PIM1, PIK3CB | 3.1807 |
TNF signaling pathway_Homo sapiens_hsa04668 | PIK3CA, PIK3CB, PTGS2, MMP9 | 2.2091 |
Insulin resistance_Homo sapiens_hsa04931 | PTPN1, PIK3CA, PIK3CB, PPARA | 2.2155 |
Linoleic acid metabolism_Homo sapiens_hsa00591 | ALOX15, CYP1A2, CYP3A4, CYP2C19 | 4.1223 |
Platelet activation_Homo sapiens_hsa04611 | PIK3CA, SRC, PIK3CB, PTGS1 | 2.0768 |
Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | PIK3CA, SRC, PIK3CB, MET | 2.7144 |
Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | PIK3CA, SRC, PIK3CB, ESR1 | 2.1139 |
Leukocyte transendothelial migration_Homo sapiens_hsa04670 | PIK3CA, MMP2, PIK3CB, MMP9 | 2.1139 |
Sphingolipid signaling pathway_Homo sapiens_hsa04071 | PIK3CA, ADORA3, ADORA1, PIK3CB | 2.0952 |
Ras signaling pathway_Homo sapiens_hsa04014 | PIK3CA, KDR, PIK3CB, MET, IGF1R | 1.9076 |
AMPK signaling pathway_Homo sapiens_hsa04152 | PIK3CA, PPARG, PIK3CB, IGF1R | 2.0661 |
FoxO signaling pathway_Homo sapiens_hsa04068 | PIK3CA, PIK3CB, GRM1, IGF1R | 1.9842 |
Hepatitis B_Homo sapiens_hsa05161 | PIK3CA, SRC, PIK3CB, MMP9 | 1.8732 |
Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | PIK3CA, ESRRB, PIK3CB, IGF1R | 1.9041 |
Oxytocin signaling pathway_Homo sapiens_hsa04921 | PIK3CA, SRC, PIK3CB, PTGS2 | 1.761 |
HIF-1 signaling pathway_Homo sapiens_hsa04066 | PIK3CA, PIK3CB, IGF1R | 1.5203 |
MAPK signaling pathway_Homo sapiens_hsa04010 | CDC25B | 0.1493 |
Osteoclast differentiation_Homo sapiens_hsa04380 | PIK3CA, PPARG, PIK3CB | 1.2731 |
Measles_Homo sapiens_hsa05162 | CSNK2A1, PIK3CA, PIK3CB | 1.2526 |
Toxoplasmosis_Homo sapiens_hsa05145 | PIK3CA, ALOX5, PIK3CB | 1.3807 |
ErbB signaling pathway_Homo sapiens_hsa04012 | PIK3CA, SRC, PIK3CB | 1.6953 |
Apoptosis_Homo sapiens_hsa04210 | PIK3CA, PIK3CB, MCL1 | 1.2404 |
Hepatitis C_Homo sapiens_hsa05160 | PIK3CA, PIK3CB, PPARA | 1.2723 |
Endocytosis_Homo sapiens_hsa04144 | SRC, KDR, MET, IGF1R | 1.1858 |
Herpes simplex infection_Homo sapiens_hsa05168 | CSNK2A1 | 0.2258 |
Insulin signaling pathway_Homo sapiens_hsa04910 | PTPN1, PIK3CA, PIK3CB | 1.2404 |
Tuberculosis_Homo sapiens_hsa05152 | SRC | 0.2337 |
Glioma_Homo sapiens_hsa05214 | PIK3CA, PIK3CB, IGF1R | 1.9842 |
Small cell lung cancer_Homo sapiens_hsa05222 | PIK3CA, PIK3CB, PTGS2 | 1.7031 |
Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | PIK3CA, PIK3CB, IGF1R | 1.9944 |
Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | PIK3CA, PIK3CB, PPARA | 1.1858 |
Long-term depression_Homo sapiens_hsa04730 | GRIA2, GRM1, IGF1R | 2.0661 |
Wnt signaling pathway_Homo sapiens_hsa04310 | CSNK2A1 | 0.2966 |
Long-term potentiation_Homo sapiens_hsa04720 | GRIA2, GRM5, GRM1 | 1.9842 |
Axon guidance_Homo sapiens_hsa04360 | MET | 0.3285 |
Cell cycle_Homo sapiens_hsa04110 | CDC25B | 0.3336 |
Oocyte meiosis_Homo sapiens_hsa04114 | IGF1R | 0.3336 |
Epstein-Barr virus infection_Homo sapiens_hsa05169 | CSNK2A1, PIK3CA, PIK3CB | 0.9527 |
Alcoholism_Homo sapiens_hsa05034 | MAOB, DRD1, DRD2 | 1.0473 |
Renal cell carcinoma_Homo sapiens_hsa05211 | PIK3CA, PIK3CB, MET | 1.9842 |
Chemokine signaling pathway_Homo sapiens_hsa04062 | PIK3CA, SRC, PIK3CB | 1.0098 |
Viral carcinogenesis_Homo sapiens_hsa05203 | PIK3CA, SRC, PIK3CB | 0.9446 |
Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | HSP90AA1, HSP90AB1 | 0.6205 |
Huntington's disease_Homo sapiens_hsa05016 | GRM5, PPARG | 0.5596 |
Purine metabolism_Homo sapiens_hsa00230 | PDE5A, XDH | 0.6064 |
Glucagon signaling pathway_Homo sapiens_hsa04922 | PPARA | 0.3957 |
Melanogenesis_Homo sapiens_hsa04916 | TYR | 0.3963 |
HTLV-I infection_Homo sapiens_hsa05166 | PIK3CA, TERT, PIK3CB | 0.769 |
Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | FLT3, KDR, MET | 0.7572 |
Influenza A_Homo sapiens_hsa05164 | PIK3CA, PIK3CB | 0.6064 |
Glycerophospholipid metabolism_Homo sapiens_hsa00564 | ACHE | 0.4112 |
Parkinson's disease_Homo sapiens_hsa05012 | DRD1, DRD2 | 0.7279 |
Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | PIK3CA, PIK3CB | 0.7029 |
Tight junction_Homo sapiens_hsa04530 | CSNK2A1, SRC | 0.7395 |
Rheumatoid arthritis_Homo sapiens_hsa05323 | MMP1 | 0.4271 |
Hematopoietic cell lineage_Homo sapiens_hsa04640 | FLT3 | 0.4271 |
Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | PIK3CA, PIK3CB | 0.7533 |
GABAergic synapse_Homo sapiens_hsa04727 | SRC | 0.4271 |
Salivary secretion_Homo sapiens_hsa04970 | CHRM3 | 0.4271 |
Neurotrophin signaling pathway_Homo sapiens_hsa04722 | PIK3CA, PIK3CB | 0.8097 |
Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | CSNK2A1 | 0.4271 |
Insulin secretion_Homo sapiens_hsa04911 | CHRM3 | 0.4306 |
Protein digestion and absorption_Homo sapiens_hsa04974 | SLC1A1 | 0.4271 |
Peroxisome_Homo sapiens_hsa04146 | XDH | 0.4363 |
GnRH signaling pathway_Homo sapiens_hsa04912 | SRC, MMP2 | 0.9574 |
Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | PIK3CA, PIK3CB | 0.9527 |
Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | PIK3CA, PIK3CB | 0.8925 |
Morphine addiction_Homo sapiens_hsa05032 | ADORA1, DRD1 | 0.9574 |
Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | PIK3CA, PIK3CB | 0.9031 |
Choline metabolism in cancer_Homo sapiens_hsa05231 | PIK3CA, PIK3CB | 0.9176 |
T cell receptor signaling pathway_Homo sapiens_hsa04660 | PIK3CA, PIK3CB | 0.9031 |
Amoebiasis_Homo sapiens_hsa05146 | PIK3CA, PIK3CB | 0.9212 |
Complement and coagulation cascades_Homo sapiens_hsa04610 | F3 | 0.451 |
Circadian entrainment_Homo sapiens_hsa04713 | GRIA2, GRIA4 | 0.9446 |
Taste transduction_Homo sapiens_hsa04742 | CHRM3, GRM1 | 1.0113 |
Pancreatic secretion_Homo sapiens_hsa04972 | CHRM3, CA2 | 0.9404 |
NF-kappa B signaling pathway_Homo sapiens_hsa04064 | CSNK2A1, PTGS2 | 0.9527 |
Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | PIK3CA, PIK3CB | 0.9326 |
Leishmaniasis_Homo sapiens_hsa05140 | PTGS2 | 0.4766 |
Adipocytokine signaling pathway_Homo sapiens_hsa04920 | PPARA | 0.4891 |
Chronic myeloid leukemia_Homo sapiens_hsa05220 | PIK3CA, PIK3CB | 1.0936 |
B cell receptor signaling pathway_Homo sapiens_hsa04662 | PIK3CA, PIK3CB | 1.0936 |
Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | PIK3CA, PIK3CB | 1.1316 |
Gastric acid secretion_Homo sapiens_hsa04971 | CHRM3, CA2 | 1.0872 |
Antigen processing and presentation_Homo sapiens_hsa04612 | HSP90AA1, HSP90AB1 | 1.0607 |
Inositol phosphate metabolism_Homo sapiens_hsa00562 | PIK3CA, PIK3CB | 1.1066 |
Bile secretion_Homo sapiens_hsa04976 | CA2, CYP3A4 | 1.1066 |
Renin secretion_Homo sapiens_hsa04924 | ADORA1 | 0.5134 |
Shigellosis_Homo sapiens_hsa05131 | SRC | 0.5134 |
Pancreatic cancer_Homo sapiens_hsa05212 | PIK3CA, PIK3CB | 1.1461 |
Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | RORC | 0.5134 |
mTOR signaling pathway_Homo sapiens_hsa04150 | PIK3CA, PIK3CB | 1.2031 |
Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | SRC, MET | 1.1316 |
Colorectal cancer_Homo sapiens_hsa05210 | PIK3CA, PIK3CB | 1.1858 |
Endometrial cancer_Homo sapiens_hsa05213 | PIK3CA, PIK3CB | 1.2731 |
Non-small cell lung cancer_Homo sapiens_hsa05223 | PIK3CA, PIK3CB | 1.2404 |
Glycerolipid metabolism_Homo sapiens_hsa00561 | AKR1B10, AKR1B1 | 1.2118 |
NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | HSP90AA1, HSP90AB1 | 1.2345 |
Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | GRIA2 | 0.5933 |
Type II diabetes mellitus_Homo sapiens_hsa04930 | PIK3CA, PIK3CB | 1.3274 |
Arginine and proline metabolism_Homo sapiens_hsa00330 | MAOB | 0.5979 |
Malaria_Homo sapiens_hsa05144 | MET | 0.6026 |
Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | ESR1 | 0.6064 |
Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | PIK3CA, PIK3CB | 1.3747 |
Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | AOX1 | 0.6064 |
Tyrosine metabolism_Homo sapiens_hsa00350 | MAOB, AOX1, TYR | 2.6596 |
Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | PIK3CA, PIK3CB | 1.4759 |
Nicotine addiction_Homo sapiens_hsa05033 | GRIA2, GRIA4 | 1.4605 |
Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | MAOB | 0.6633 |
Galactose metabolism_Homo sapiens_hsa00052 | AKR1B10, AKR1B1 | 1.6718 |
Thyroid cancer_Homo sapiens_hsa05216 | PPARG | 0.766 |
Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | FUT7 | 0.752 |
Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | AKR1B10, AKR1B1 | 1.5308 |
Fructose and mannose metabolism_Homo sapiens_hsa00051 | AKR1B10, AKR1B1 | 1.6234 |
Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | AOX1 | 0.766 |
Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | FUT7 | 0.7967 |
Circadian rhythm_Homo sapiens_hsa04710 | RORC | 0.7572 |
Collecting duct acid secretion_Homo sapiens_hsa04966 | CA2 | 0.7849 |
Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | CA2, CA4 | 1.8732 |
Histidine metabolism_Homo sapiens_hsa00340 | MAOB | 0.8225 |
Phenylalanine metabolism_Homo sapiens_hsa00360 | MAOB | 0.9401 |
Folate biosynthesis_Homo sapiens_hsa00790 | ALPL | 0.9863 |
Caffeine metabolism_Homo sapiens_hsa00232 | CYP2A6, CYP1A2, XDH | 4.9952 |
Vitamin B6 metabolism_Homo sapiens_hsa00750 | AOX1 | 1.2473 |